,date,title,url
0,2000-03-16,竹林众生年报,/disclosure/listedinfo/announcement/c/600222_1999_0.pdf
1,2000-07-26,竹林众生半年报,/disclosure/listedinfo/announcement/c/600222_2000_1.pdf
2,2001-02-16,竹林众生年报,/disclosure/listedinfo/announcement/c/600222_2000_0.pdf
3,2001-04-24,竹林众生上市公司章程,/disclosure/listedinfo/announcement/c/600222_2001_g.pdf
4,2001-07-17,竹林众生半年报,/disclosure/listedinfo/announcement/c/600222_2001_1.pdf
5,2002-03-01,竹林众生年报,/disclosure/listedinfo/announcement/c/600222_2001_n.pdf
6,2002-04-20,竹林众生第一季度季报,/disclosure/listedinfo/announcement/c/600222_2002_1.pdf
7,2002-05-31,竹林众生章程修改议案,/disclosure/listedinfo/announcement/c/600222_20020531_1.pdf
8,2002-06-22,竹林众生股东大会决议公告,/disclosure/listedinfo/announcement/c/600222_20020622_1.pdf
9,2002-06-22,竹林众生股东大会会议资料,/disclosure/listedinfo/announcement/c/600222_20020622_3.pdf
10,2002-06-22,竹林众生股东大会会议资料,/disclosure/listedinfo/announcement/c/600222_20020622_2.pdf
11,2002-07-02,竹林众生上市公司章程,/disclosure/listedinfo/announcement/c/600222_20020702_g.pdf
12,2002-07-02,竹林众生股东大会决议公告,/disclosure/listedinfo/announcement/c/600222_20020702_1.pdf
13,2002-08-10,竹林众生半年报,/disclosure/listedinfo/announcement/c/2002-08-10/600222_2002_z.pdf
14,2002-08-22,竹林众生股东大会会议资料,/disclosure/listedinfo/announcement/c/2002-08-22/600222_20020822_1.pdf
15,2002-09-24,竹林众生上市公司章程,/disclosure/listedinfo/announcement/c/2002-09-24/600222_20020924_g.pdf
16,2002-09-24,竹林众生股东大会决议公告,/disclosure/listedinfo/announcement/c/2002-09-24/600222_20020924_1.pdf
17,2002-10-26,竹林众生第三季度季报,/disclosure/listedinfo/announcement/c/2002-10-26/600222_2002_3.pdf
18,2003-04-10,竹林众生年报,/disclosure/listedinfo/announcement/c/2003-04-10/600222_2002_n.pdf
19,2003-04-10,竹林众生股东大会会议资料,/disclosure/listedinfo/announcement/c/2003-04-10/600222_20030410_1.pdf
20,2003-04-19,竹林众生第一季度季报,/disclosure/listedinfo/announcement/c/2003-04-19/600222_2003_1.pdf
21,2003-05-13,竹林众生股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-05-13/600222_20030513_1.pdf
22,2003-06-25,竹林众生股东大会会议资料,/disclosure/listedinfo/announcement/c/2003-06-25/600222_20030625_1.pdf
23,2003-08-16,竹林众生半年报,/disclosure/listedinfo/announcement/c/2003-08-16/600222_2003_z.pdf
24,2003-08-30,竹林众生股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-08-30/600222_20030830_1.pdf
25,2003-10-25,竹林众生第三季度季报,/disclosure/listedinfo/announcement/c/2003-10-25/600222_2003_3.pdf
26,2003-12-23,竹林众生投资者关系管理制度,/disclosure/listedinfo/announcement/c/2003-12-23/600222_20031223_2.pdf
27,2003-12-23,竹林众生董事会公告,/disclosure/listedinfo/announcement/c/2003-12-23/600222_20031223_1.pdf
28,2004-04-02,竹林众生董事会公告,/disclosure/listedinfo/announcement/c/2004-04-02/600222_20040402_1.pdf
29,2004-04-17,竹林众生年报,/disclosure/listedinfo/announcement/c/2004-04-17/600222_2003_n.pdf
30,2004-04-17,竹林众生监事会决议公告,/disclosure/listedinfo/announcement/c/2004-04-17/600222_20040417_3.pdf
31,2004-04-17,竹林众生对外担保管理制度（草案）,/disclosure/listedinfo/announcement/c/2004-04-17/600222_20040417_5.pdf
32,2004-04-17,竹林众生董事会决议公告暨召开2003年度股东大会通知,/disclosure/listedinfo/announcement/c/2004-04-17/600222_20040417_2.pdf
33,2004-04-17,竹林众生董事会公告,/disclosure/listedinfo/announcement/c/2004-04-17/600222_20040417_1.pdf
34,2004-04-17,竹林众生2003年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2004-04-17/600222_20040417_4.pdf
35,2004-04-24,竹林众生第一季度季报,/disclosure/listedinfo/announcement/c/2004-04-24/600222_2004_1.pdf
36,2004-05-22,竹林众生2003年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-05-22/600222_20040522_1.pdf
37,2004-05-22,竹林众生2003年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2004-05-22/600222_20040522_2.pdf
38,2004-06-02,竹林众生年报补充公告,/disclosure/listedinfo/announcement/c/2004-06-02/600222_20040602_1.pdf
39,2004-07-30,竹林众生监事会决议公告,/disclosure/listedinfo/announcement/c/2004-07-30/600222_20040730_3.pdf
40,2004-07-30,竹林众生股东大会会议资料,/disclosure/listedinfo/announcement/c/2004-07-30/600222_20040730_1.pdf
41,2004-07-30,竹林众生董事会决议暨召开临时股东大会公告,/disclosure/listedinfo/announcement/c/2004-07-30/600222_20040730_2.pdf
42,2004-08-21,竹林众生半年报摘要,/disclosure/listedinfo/announcement/c/2004-08-21/600222_2004_zzy.pdf
43,2004-08-21,竹林众生半年报,/disclosure/listedinfo/announcement/c/2004-08-21/600222_2004_z.pdf
44,2004-08-31,竹林众生上市公司章程,/disclosure/listedinfo/announcement/c/2004-08-31/600222_20040831_g.pdf
45,2004-08-31,竹林众生监事会决议公告,/disclosure/listedinfo/announcement/c/2004-08-31/600222_20040831_4.pdf
46,2004-08-31,竹林众生董事会决议公告,/disclosure/listedinfo/announcement/c/2004-08-31/600222_20040831_3.pdf
47,2004-08-31,竹林众生2004年度第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-08-31/600222_20040831_1.pdf
48,2004-08-31,竹林众生2004年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2004-08-31/600222_20040831_2.pdf
49,2004-10-21,竹林众生董事会公告,/disclosure/listedinfo/announcement/c/2004-10-21/600222_20041021_1.pdf
50,2004-10-22,竹林众生董事会公告,/disclosure/listedinfo/announcement/c/2004-10-22/600222_20041022_1.pdf
51,2004-10-28,竹林众生第三季度季报,/disclosure/listedinfo/announcement/c/2004-10-28/600222_2004_3.pdf
52,2004-10-30,竹林众生董事会公告,/disclosure/listedinfo/announcement/c/2004-10-30/600222_20041030_1.pdf
53,2004-11-24,竹林众生董事会公告,/disclosure/listedinfo/announcement/c/2004-11-24/600222_20041124_1.pdf
54,2004-12-11,竹林众生董事会公告,/disclosure/listedinfo/announcement/c/2004-12-11/600222_20041211_1.pdf
55,2005-01-28,竹林众生董事会决议公告,/disclosure/listedinfo/announcement/c/2005-01-28/600222_20050128_1.pdf
56,2005-02-18,竹林众生董事会决议暨召开临时股东大会公告,/disclosure/listedinfo/announcement/c/2005-02-18/600222_20050218_1.pdf
57,2005-02-18,竹林众生2005年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2005-02-18/600222_20050218_2.pdf
58,2005-03-22,竹林众生董事会关于变更对外联系方式的公告,/disclosure/listedinfo/announcement/c/2005-03-22/600222_20050322_2.pdf
59,2005-03-22,竹林众生2005年度第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2005-03-22/600222_20050322_3.pdf
60,2005-03-22,竹林众生2005年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-03-22/600222_20050322_1.pdf
61,2005-04-14,竹林众生董事会决议公告,/disclosure/listedinfo/announcement/c/2005-04-14/600222_20050414_1.pdf
62,2005-04-19,竹林众生年报摘要,/disclosure/listedinfo/announcement/c/2005-04-19/600222_2004_nzy.pdf
63,2005-04-19,竹林众生年报,/disclosure/listedinfo/announcement/c/2005-04-19/600222_2004_n.pdf
64,2005-04-19,竹林众生监事会决议公告,/disclosure/listedinfo/announcement/c/2005-04-19/600222_20050419_3.pdf
65,2005-04-19,竹林众生董事会决议暨召开2004年年度股东大会公告,/disclosure/listedinfo/announcement/c/2005-04-19/600222_20050419_2.pdf
66,2005-04-19,竹林众生2004年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2005-04-19/600222_20050419_1.pdf
67,2005-04-28,竹林众生第一季度季报,/disclosure/listedinfo/announcement/c/2005-04-28/600222_2005_1.pdf
68,2005-04-30,竹林众生董事会决议公告,/disclosure/listedinfo/announcement/c/2005-04-30/600222_20050430_1.pdf
69,2005-05-12,竹林众生董事会公告,/disclosure/listedinfo/announcement/c/2005-05-12/600222_20050512_1.pdf
70,2005-05-21,竹林众生上市公司章程,/disclosure/listedinfo/announcement/c/2005-05-21/600222_20050521_g.pdf
71,2005-05-21,竹林众生2004年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-05-21/600222_20050521_1.pdf
72,2005-05-21,竹林众生2004年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2005-05-21/600222_20050521_2.pdf
73,2005-07-30,竹林众生半年报摘要,/disclosure/listedinfo/announcement/c/2005-07-30/600222_2005_zzy.pdf
74,2005-07-30,竹林众生半年报,/disclosure/listedinfo/announcement/c/2005-07-30/600222_2005_z.pdf
75,2005-08-09,竹林众生董事会公告,/disclosure/listedinfo/announcement/c/2005-08-09/600222_20050809_1.pdf
76,2005-08-24,竹林众生董事会决议公告,/disclosure/listedinfo/announcement/c/2005-08-24/600222_20050824_1.pdf
77,2005-10-26,竹林众生第三季度季报,/disclosure/listedinfo/announcement/c/2005-10-26/600222_2005_3.pdf
78,2005-11-25,竹林众生董事会决议公告,/disclosure/listedinfo/announcement/c/2005-11-25/600222_20051125_1.pdf
79,2005-12-01,竹林众生董事会决议公告,/disclosure/listedinfo/announcement/c/2005-12-01/600222_20051201_1.pdf
80,2005-12-13,竹林众生董事会决议暨召开2006年第一次临时股东大会公告,/disclosure/listedinfo/announcement/c/2005-12-13/600222_20051213_1.pdf
81,2005-12-13,竹林众生2006年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2005-12-13/600222_20051213_2.pdf
82,2006-01-14,竹林众生2006年度第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-01-14/600222_20060114_2.pdf
83,2006-01-14,竹林众生2006年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-01-14/600222_20060114_1.pdf
84,2006-02-07,竹林众生董事会决议公告,/disclosure/listedinfo/announcement/c/2006-02-07/600222_20060207_1.pdf
85,2006-02-21,竹林众生董事会决议暨召开临时股东大会公告,/disclosure/listedinfo/announcement/c/2006-02-21/600222_20060221_1.pdf
86,2006-03-25,竹林众生2006年度第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-03-25/600222_20060325_2.pdf
87,2006-03-25,竹林众生2006年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-03-25/600222_20060325_1.pdf
88,2006-03-29,竹林众生关于变更公司名称及证券简称的公告,/disclosure/listedinfo/announcement/c/2006-03-29/600222_20060329_1.pdf
89,2006-04-13,太龙药业关于控股股东转让持有公司股权的提示性公告,/disclosure/listedinfo/announcement/c/2006-04-13/600222_20060413_1.pdf
90,2006-04-13,太龙药业股东增持持股变动报告书,/disclosure/listedinfo/announcement/c/2006-04-13/600222_20060413_3.pdf
91,2006-04-13,太龙药业股东减持持股变动报告书,/disclosure/listedinfo/announcement/c/2006-04-13/600222_20060413_2.pdf
92,2006-04-17,太龙药业关于进行股权分置改革的提示性公告,/disclosure/listedinfo/announcement/c/2006-04-17/600222_20060417_1.pdf
93,2006-04-20,太龙药业年报摘要,/disclosure/listedinfo/announcement/c/2006-04-20/600222_2005_nzy.pdf
94,2006-04-20,太龙药业年报,/disclosure/listedinfo/announcement/c/2006-04-20/600222_2005_n.pdf
95,2006-04-20,太龙药业监事会决议公告,/disclosure/listedinfo/announcement/c/2006-04-20/600222_20060420_2.pdf
96,2006-04-20,太龙药业董事会决议暨召开2005年年度股东大会公告,/disclosure/listedinfo/announcement/c/2006-04-20/600222_20060420_1.pdf
97,2006-04-20,太龙药业2005年控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2006-04-20/600222_20060420_3.pdf
98,2006-04-24,太龙药业第一季度季报,/disclosure/listedinfo/announcement/c/2006-04-24/600222_2006_1.pdf
99,2006-04-25,太龙药业关于股权分置改革工作进程的提示性公告,/disclosure/listedinfo/announcement/c/2006-04-25/600222_20060425_1.pdf
100,2006-04-26,太龙药业董事会公告,/disclosure/listedinfo/announcement/c/2006-04-26/600222_20060426_1.pdf
101,2006-05-10,太龙药业关于股权分置改革工作进程的公告,/disclosure/listedinfo/announcement/c/2006-05-10/600222_20060510_1.pdf
102,2006-05-15,太龙药业股权分置改革之保荐意见书,/disclosure/listedinfo/announcement/c/2006-05-15/600222_20060515_3.pdf
103,2006-05-15,太龙药业股权分置改革说明书（摘要）,/disclosure/listedinfo/announcement/c/2006-05-15/600222_20060515_2.pdf
104,2006-05-15,太龙药业股权分置改革说明书,/disclosure/listedinfo/announcement/c/2006-05-15/600222_20060515_1.pdf
105,2006-05-15,太龙药业股权分置改革事宜的法律意见书,/disclosure/listedinfo/announcement/c/2006-05-15/600222_20060515_4.pdf
106,2006-05-15,太龙药业独立董事关于公司股权分置改革方案的独立董事意见,/disclosure/listedinfo/announcement/c/2006-05-15/600222_20060515_5.pdf
107,2006-05-16,太龙药业关于举办股权分置改革网上投资者交流会的公告,/disclosure/listedinfo/announcement/c/2006-05-16/600222_20060516_1.pdf
108,2006-05-17,太龙药业董事会公告,/disclosure/listedinfo/announcement/c/2006-05-17/600222_20060517_1.pdf
109,2006-05-23,太龙药业2005年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-05-23/600222_20060523_1.pdf
110,2006-05-23,太龙药业2005年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-05-23/600222_20060523_2.pdf
111,2006-05-24,太龙药业关于股权分置改革方案沟通协商情况暨调整股权分置改革方案的公告,/disclosure/listedinfo/announcement/c/2006-05-24/600222_20060524_1.pdf
112,2006-05-24,太龙药业股权分置改革之补充保荐意见,/disclosure/listedinfo/announcement/c/2006-05-24/600222_20060524_4.pdf
113,2006-05-24,太龙药业股权分置改革说明书摘要（修订稿）,/disclosure/listedinfo/announcement/c/2006-05-24/600222_20060524_3.pdf
114,2006-05-24,太龙药业股权分置改革说明书（修订稿）,/disclosure/listedinfo/announcement/c/2006-05-24/600222_20060524_2.pdf
115,2006-05-24,太龙药业股权分置改革事宜的补充法律意见书,/disclosure/listedinfo/announcement/c/2006-05-24/600222_20060524_5.pdf
116,2006-05-24,太龙药业独立董事关于调整公司股权分置改革方案的独立董事意见,/disclosure/listedinfo/announcement/c/2006-05-24/600222_20060524_6.pdf
117,2006-05-30,太龙药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2006-05-30/600222_20060530_1.pdf
118,2006-07-08,太龙药业董事会公告,/disclosure/listedinfo/announcement/c/2006-07-08/600222_20060708_1.pdf
119,2006-07-17,太龙药业董事会投票委托征集函,/disclosure/listedinfo/announcement/c/2006-07-17/600222_20060717_2.pdf
120,2006-07-17,太龙药业董事会关于召开2006年度第三次临时股东大会暨相关股东会议的通知,/disclosure/listedinfo/announcement/c/2006-07-17/600222_20060717_1.pdf
121,2006-07-29,太龙药业董事会决议公告,/disclosure/listedinfo/announcement/c/2006-07-29/600222_20060729_1.pdf
122,2006-07-29,太龙药业半年报摘要,/disclosure/listedinfo/announcement/c/2006-07-29/600222_2006_zzy.pdf
123,2006-07-29,太龙药业半年报,/disclosure/listedinfo/announcement/c/2006-07-29/600222_2006_z.pdf
124,2006-08-02,太龙药业关于股权分置改革方案获得河南省国资委批复的公告,/disclosure/listedinfo/announcement/c/2006-08-02/600222_20060802_1.pdf
125,2006-08-08,太龙药业关于股权转让过户完成的公告,/disclosure/listedinfo/announcement/c/2006-08-08/600222_20060808_2.pdf
126,2006-08-08,太龙药业董事会公告,/disclosure/listedinfo/announcement/c/2006-08-08/600222_20060808_1.pdf
127,2006-08-10,太龙药业关于资本公积专项审计报告的公告,/disclosure/listedinfo/announcement/c/2006-08-10/600222_20060810_2.pdf
128,2006-08-10,太龙药业董事会关于召开2006年度第三次临时股东大会暨相关股东会议的第一次提示性公告,/disclosure/listedinfo/announcement/c/2006-08-10/600222_20060810_1.pdf
129,2006-08-15,太龙药业董事会关于召开2006年度第三次临时股东大会暨相关股东会议的第二次提示性公告,/disclosure/listedinfo/announcement/c/2006-08-15/600222_20060815_1.pdf
130,2006-08-21,太龙药业股权分置改革相关股东会议的法律意见书,/disclosure/listedinfo/announcement/c/2006-08-21/600222_20060821_2.pdf
131,2006-08-21,太龙药业2006年度第三次临时股东大会暨相关股东会议的表决结果公告,/disclosure/listedinfo/announcement/c/2006-08-21/600222_20060821_1.pdf
132,2006-08-23,太龙药业股权分置改革方案实施公告,/disclosure/listedinfo/announcement/c/2006-08-23/600222_20060823_1.pdf
133,2006-08-29,G太龙资本公积金转增股本方案实施的公告,/disclosure/listedinfo/announcement/c/2006-08-29/600222_20060829_1.pdf
134,2006-09-07,G太龙董事会决议暨召开临时股东大会的公告,/disclosure/listedinfo/announcement/c/2006-09-07/600222_20060907_1.pdf
135,2006-09-26,G太龙2006年度第四次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-09-26/600222_20060926_2.pdf
136,2006-09-26,G太龙2006年第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-09-26/600222_20060926_1.pdf
137,2006-10-23,太龙药业第三季度季报,/disclosure/listedinfo/announcement/c/2006-10-23/600222_2006_3.pdf
138,2006-10-27,太龙药业股东股权质押公告,/disclosure/listedinfo/announcement/c/2006-10-27/600222_20061027_1.pdf
139,2006-10-31,太龙药业股东股权冻结公告,/disclosure/listedinfo/announcement/c/2006-10-31/600222_20061031_1.pdf
140,2006-11-02,太龙药业公布重大事项公告,/disclosure/listedinfo/announcement/c/2006-11-02/600222_20061102_1.pdf
141,2006-11-04,太龙药业关于更换监事的公告,/disclosure/listedinfo/announcement/c/2006-11-04/600222_20061104_1.pdf
142,2006-11-22,太龙药业董事会决议公告,/disclosure/listedinfo/announcement/c/2006-11-22/600222_20061122_1.pdf
143,2006-12-30,太龙药业董事会公告,/disclosure/listedinfo/announcement/c/2006-12-30/600222_20061230_1.pdf
144,2007-01-20,太龙药业董事会决议暨召开临时股东大会的公告,/disclosure/listedinfo/announcement/c/2007-01-20/600222_20070120_1.pdf
145,2007-02-06,太龙药业2007年度第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-02-06/600222_20070206_2.pdf
146,2007-02-06,太龙药业2007年第一次临时股东大会决议的公告,/disclosure/listedinfo/announcement/c/2007-02-06/600222_20070206_1.pdf
147,2007-02-08,太龙药业股东股权冻结公告,/disclosure/listedinfo/announcement/c/2007-02-08/600222_20070208_1.pdf
148,2007-02-10,太龙药业董事会决议暨召开临时股东大会的公告,/disclosure/listedinfo/announcement/c/2007-02-10/600222_20070210_1.pdf
149,2007-02-27,太龙药业2007年度第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-02-27/600222_20070227_2.pdf
150,2007-02-27,太龙药业2007年第二次临时股东大会决议的公告,/disclosure/listedinfo/announcement/c/2007-02-27/600222_20070227_1.pdf
151,2007-03-01,太龙药业股票异常波动公告,/disclosure/listedinfo/announcement/c/2007-03-01/600222_20070301_1.pdf
152,2007-04-21,太龙药业年报摘要,/disclosure/listedinfo/announcement/c/2007-04-21/600222_2006_nzy.pdf
153,2007-04-21,太龙药业年报,/disclosure/listedinfo/announcement/c/2007-04-21/600222_2006_n.pdf
154,2007-04-21,太龙药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-21/600222_20070421_2.pdf
155,2007-04-21,太龙药业董事会决议暨召开2006年年度股东大会公告,/disclosure/listedinfo/announcement/c/2007-04-21/600222_20070421_1.pdf
156,2007-04-21,太龙药业2006年控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2007-04-21/600222_20070421_3.pdf
157,2007-04-28,太龙药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-28/600222_20070428_2.pdf
158,2007-04-28,太龙药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-28/600222_20070428_1.pdf
159,2007-04-28,太龙药业第一季度季报,/disclosure/listedinfo/announcement/c/2007-04-28/600222_2007_1.pdf
160,2007-05-17,太龙药业2006年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-05-17/600222_20070517_1.pdf
161,2007-05-17,太龙药业2006年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-05-17/600222_20070517_2.pdf
162,2007-06-02,太龙药业股票异常波动公告,/disclosure/listedinfo/announcement/c/2007-06-02/600222_20070602_1.pdf
163,2007-06-28,太龙药业董事会决议暨召开临时股东大会的公告,/disclosure/listedinfo/announcement/c/2007-06-28/600222_20070628_1.pdf
164,2007-06-30,太龙药业治理情况的自查报告和整改计划,/disclosure/listedinfo/announcement/c/2007-06-30/600222_20070630_3.pdf
165,2007-06-30,太龙药业信息披露管理制度,/disclosure/listedinfo/announcement/c/2007-06-30/600222_20070630_5.pdf
166,2007-06-30,太龙药业投资者关系管理制度（2007修订）,/disclosure/listedinfo/announcement/c/2007-06-30/600222_20070630_4.pdf
167,2007-06-30,太龙药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-06-30/600222_20070630_2.pdf
168,2007-06-30,太龙药业独立董事制度（2007修订）,/disclosure/listedinfo/announcement/c/2007-06-30/600222_20070630_6.pdf
169,2007-06-30,太龙药业董事会决议暨召开临时股东大会的公告,/disclosure/listedinfo/announcement/c/2007-06-30/600222_20070630_1.pdf
170,2007-07-03,太龙药业双黄连口服液获得执行优质优价批复的公告,/disclosure/listedinfo/announcement/c/2007-07-03/600222_20070703_1.pdf
171,2007-07-14,太龙药业2007年度第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-07-14/600222_20070714_2.pdf
172,2007-07-14,太龙药业2007年第三次临时股东大会决议的公告,/disclosure/listedinfo/announcement/c/2007-07-14/600222_20070714_1.pdf
173,2007-07-17,太龙药业2007年半年度业绩预增的公告,/disclosure/listedinfo/announcement/c/2007-07-17/600222_20070717_1.pdf
174,2007-07-19,太龙药业2007年度第四次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-07-19/600222_20070719_2.pdf
175,2007-07-19,太龙药业2007年第四次临时股东大会决议的公告,/disclosure/listedinfo/announcement/c/2007-07-19/600222_20070719_1.pdf
176,2007-08-11,太龙药业职工代表大会决议的公告,/disclosure/listedinfo/announcement/c/2007-08-11/600222_20070811_3.pdf
177,2007-08-11,太龙药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-08-11/600222_20070811_2.pdf
178,2007-08-11,太龙药业董事会决议暨召开临时股东大会的公告,/disclosure/listedinfo/announcement/c/2007-08-11/600222_20070811_1.pdf
179,2007-08-22,太龙药业控股股东部分股份解除冻结的公告,/disclosure/listedinfo/announcement/c/2007-08-22/600222_20070822_1.pdf
180,2007-08-28,太龙药业有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2007-08-28/600222_20070828_1.pdf
181,2007-08-28,太龙药业半年报摘要,/disclosure/listedinfo/announcement/c/2007-08-28/600222_2007_zzy.pdf
182,2007-08-28,太龙药业半年报,/disclosure/listedinfo/announcement/c/2007-08-28/600222_2007_z.pdf
183,2007-08-28,太龙药业2007年度第五次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-08-28/600222_20070828_3.pdf
184,2007-08-28,太龙药业2007年第五次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-08-28/600222_20070828_2.pdf
185,2007-09-01,太龙药业关于更换保荐代表人的公告,/disclosure/listedinfo/announcement/c/2007-09-01/600222_20070901_1.pdf
186,2007-09-04,太龙药业控股股东误买入股票情况的公告,/disclosure/listedinfo/announcement/c/2007-09-04/600222_20070904_1.pdf
187,2007-09-25,太龙药业控股股东出售股票情况的公告,/disclosure/listedinfo/announcement/c/2007-09-25/600222_20070925_1.pdf
188,2007-10-13,太龙药业控股股东出售股票情况的公告,/disclosure/listedinfo/announcement/c/2007-10-13/600222_20071013_1.pdf
189,2007-10-17,太龙药业控股股东出售股票情况的公告,/disclosure/listedinfo/announcement/c/2007-10-17/600222_20071017_1.pdf
190,2007-10-18,太龙药业关于控股股东限售流通股股权续冻公告,/disclosure/listedinfo/announcement/c/2007-10-18/600222_20071018_1.pdf
191,2007-10-19,太龙药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-10-19/600222_20071019_2.pdf
192,2007-10-19,太龙药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-10-19/600222_20071019_1.pdf
193,2007-10-26,太龙药业第三季度季报,/disclosure/listedinfo/announcement/c/2007-10-26/600222_2007_3.pdf
194,2007-11-08,太龙药业公司治理整改情况报告,/disclosure/listedinfo/announcement/c/2007-11-08/600222_20071108_2.pdf
195,2007-11-08,太龙药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-11-08/600222_20071108_1.pdf
196,2007-11-10,太龙药业股东股权冻结公告,/disclosure/listedinfo/announcement/c/2007-11-10/600222_20071110_1.pdf
197,2007-12-27,太龙药业控股子公司股权转让的公告,/disclosure/listedinfo/announcement/c/2007-12-27/600222_20071227_1.pdf
198,2008-01-09,太龙药业公告,/disclosure/listedinfo/announcement/c/2008-01-09/600222_20080109_1.pdf
199,2008-01-26,太龙药业关联交易的公告,/disclosure/listedinfo/announcement/c/2008-01-26/600222_20080126_1.pdf
200,2008-02-02,太龙药业控股股东豁免公司下属控股子公司债务的公告,/disclosure/listedinfo/announcement/c/2008-02-02/600222_20080202_1.pdf
201,2008-02-14,太龙药业关于控股股东限售流通股股权续冻公告,/disclosure/listedinfo/announcement/c/2008-02-14/600222_20080214_1.pdf
202,2008-02-20,太龙药业董事会决议暨召开临时股东大会的公告,/disclosure/listedinfo/announcement/c/2008-02-20/600222_20080220_1.pdf
203,2008-02-20,太龙药业第四届董事会第七次会议决议暨对外担保的公告,/disclosure/listedinfo/announcement/c/2008-02-20/600222_20080220_2.pdf
204,2008-02-27,太龙药业股东出售股票情况的公告,/disclosure/listedinfo/announcement/c/2008-02-27/600222_20080227_1.pdf
205,2008-03-07,太龙药业2008年第一次临时股东大会决议的公告,/disclosure/listedinfo/announcement/c/2008-03-07/600222_20080307_1.pdf
206,2008-03-07,太龙药业2008年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-03-07/600222_20080307_2.pdf
207,2008-03-27,太龙药业股东出售股票情况的公告,/disclosure/listedinfo/announcement/c/2008-03-27/600222_20080327_1.pdf
208,2008-03-29,太龙药业年报摘要,/disclosure/listedinfo/announcement/c/2008-03-29/600222_2007_nzy.pdf
209,2008-03-29,太龙药业年报,/disclosure/listedinfo/announcement/c/2008-03-29/600222_2007_n.pdf
210,2008-03-29,太龙药业控股股东及其他关联方资金占用情况的专项意见,/disclosure/listedinfo/announcement/c/2008-03-29/600222_20080329_3.pdf
211,2008-03-29,太龙药业监事会决议公告,/disclosure/listedinfo/announcement/c/2008-03-29/600222_20080329_2.pdf
212,2008-03-29,太龙药业董事会决议公告暨召开2007年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2008-03-29/600222_20080329_1.pdf
213,2008-04-16,太龙药业2007年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-04-16/600222_20080416_1.pdf
214,2008-04-19,太龙药业2007年年度股东大会决议的公告,/disclosure/listedinfo/announcement/c/2008-04-19/600222_20080419_1.pdf
215,2008-04-19,太龙药业2007年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-04-19/600222_20080419_2.pdf
216,2008-04-24,太龙药业股权质押的公告,/disclosure/listedinfo/announcement/c/2008-04-24/600222_20080424_1.pdf
217,2008-04-26,太龙药业董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2008-04-26/600222_20080426_1.pdf
218,2008-04-26,太龙药业第一季度季报,/disclosure/listedinfo/announcement/c/2008-04-26/600222_2008_1.pdf
219,2008-05-05,太龙药业关于控股股东限售流通股股权续冻公告,/disclosure/listedinfo/announcement/c/2008-05-05/600222_20080505_1.pdf
220,2008-05-09,太龙药业2008年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-05-09/600222_20080509_1.pdf
221,2008-05-16,太龙药业2008年第二次临时股东大会决议的公告,/disclosure/listedinfo/announcement/c/2008-05-16/600222_20080516_1.pdf
222,2008-05-16,太龙药业2008年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-05-16/600222_20080516_2.pdf
223,2008-05-22,太龙药业捐赠的公告,/disclosure/listedinfo/announcement/c/2008-05-22/600222_20080522_1.pdf
224,2008-05-28,太龙药业2007年度分红送股方案实施的公告,/disclosure/listedinfo/announcement/c/2008-05-28/600222_20080528_1.pdf
225,2008-06-26,太龙药业股东出售股票情况的公告,/disclosure/listedinfo/announcement/c/2008-06-26/600222_20080626_1.pdf
226,2008-07-18,太龙药业公司治理整改报告中所列事项的治理整改情况说明,/disclosure/listedinfo/announcement/c/2008-07-18/600222_20080718_2.pdf
227,2008-07-18,太龙药业董事会决议公告,/disclosure/listedinfo/announcement/c/2008-07-18/600222_20080718_1.pdf
228,2008-07-29,太龙药业关于控股股东限售流通股股权续冻公告,/disclosure/listedinfo/announcement/c/2008-07-29/600222_20080729_1.pdf
229,2008-08-16,太龙药业第四届董事会第十一次会议决议的公告暨召开2008年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2008-08-16/600222_20080816_1.pdf
230,2008-08-19,太龙药业半年报摘要,/disclosure/listedinfo/announcement/c/2008-08-19/600222_2008_zzy.pdf
231,2008-08-19,太龙药业半年报,/disclosure/listedinfo/announcement/c/2008-08-19/600222_2008_z.pdf
232,2008-08-26,太龙药业2008年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-08-26/600222_20080826_1.pdf
233,2008-09-03,太龙药业2008年第三次临时股东大会决议的公告,/disclosure/listedinfo/announcement/c/2008-09-03/600222_20080903_1.pdf
234,2008-09-03,太龙药业2008年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-09-03/600222_20080903_2.pdf
235,2008-09-13,太龙药业股东部分股权解除质押和续质押的公告,/disclosure/listedinfo/announcement/c/2008-09-13/600222_20080913_1.pdf
236,2008-09-22,太龙药业股票异常波动公告,/disclosure/listedinfo/announcement/c/2008-09-22/600222_20080922_1.pdf
237,2008-10-25,太龙药业第三季度季报,/disclosure/listedinfo/announcement/c/2008-10-25/600222_2008_3.pdf
238,2008-11-06,太龙药业有限售条件的流通股上市流通的公告,/disclosure/listedinfo/announcement/c/2008-11-06/600222_20081106_1.pdf
239,2008-11-08,太龙药业股东部分股权解除质押和续质押的公告,/disclosure/listedinfo/announcement/c/2008-11-08/600222_20081108_1.pdf
240,2008-11-11,太龙药业关于控股股东部分限售流通股股权冻结的公告,/disclosure/listedinfo/announcement/c/2008-11-11/600222_20081111_1.pdf
241,2008-12-03,太龙药业股东出售股票情况的公告,/disclosure/listedinfo/announcement/c/2008-12-03/600222_20081203_1.pdf
242,2009-01-14,太龙药业获得高新技术企业认定的公告,/disclosure/listedinfo/announcement/c/2009-01-14/600222_20090114_2.pdf
243,2009-01-14,太龙药业第四届董事会第十五次会议决议的公告,/disclosure/listedinfo/announcement/c/2009-01-14/600222_20090114_1.pdf
244,2009-02-18,太龙药业关于职工监事变更的公告,/disclosure/listedinfo/announcement/c/2009-02-18/600222_20090218_1.pdf
245,2009-02-18,太龙药业第四届董事会第十六次会议决议的公告,/disclosure/listedinfo/announcement/c/2009-02-18/600222_20090218_2.pdf
246,2009-03-06,太龙药业年报摘要,/disclosure/listedinfo/announcement/c/2009-03-06/600222_2008_nzy.pdf
247,2009-03-06,太龙药业年报,/disclosure/listedinfo/announcement/c/2009-03-06/600222_2008_n.pdf
248,2009-03-06,太龙药业控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2009-03-06/600222_20090306_3.pdf
249,2009-03-06,太龙药业董事会审计委员会年报工作规程,/disclosure/listedinfo/announcement/c/2009-03-06/600222_20090306_4.pdf
250,2009-03-06,太龙药业第四届监事会第七次会议决议的公告,/disclosure/listedinfo/announcement/c/2009-03-06/600222_20090306_2.pdf
251,2009-03-06,太龙药业第四届董事会第十七次会议决议的公告暨召开2008年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2009-03-06/600222_20090306_1.pdf
252,2009-03-17,太龙药业股东出售股票情况的公告,/disclosure/listedinfo/announcement/c/2009-03-17/600222_20090317_1.pdf
253,2009-03-21,太龙药业2008年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-03-21/600222_20090321_1.pdf
254,2009-03-28,太龙药业公司章程（2009修订）,/disclosure/listedinfo/announcement/c/2009-03-28/600222_20090328_g.pdf
255,2009-03-28,太龙药业2008年年度股东大会决议的公告,/disclosure/listedinfo/announcement/c/2009-03-28/600222_20090328_1.pdf
256,2009-03-28,太龙药业2008年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-03-28/600222_20090328_2.pdf
257,2009-04-09,太龙药业股东股权过户的公告,/disclosure/listedinfo/announcement/c/2009-04-09/600222_20090409_1.pdf
258,2009-04-16,太龙药业关于控股股东限售流通股股权续冻公告,/disclosure/listedinfo/announcement/c/2009-04-16/600222_20090416_1.pdf
259,2009-04-25,太龙药业第一季度季报,/disclosure/listedinfo/announcement/c/2009-04-25/600222_2009_1.pdf
260,2009-04-25,太龙药业第四届董事会第十八次会议决议的公告,/disclosure/listedinfo/announcement/c/2009-04-25/600222_20090425_1.pdf
261,2009-05-12,太龙药业关于控股股东部分股权解冻与冻结的公告,/disclosure/listedinfo/announcement/c/2009-05-12/600222_20090512_1.pdf
262,2009-05-13,太龙药业股东部分股权解除质押和续质押的公告,/disclosure/listedinfo/announcement/c/2009-05-13/600222_20090513_1.pdf
263,2009-05-15,太龙药业股东出售股票情况的公告,/disclosure/listedinfo/announcement/c/2009-05-15/600222_20090515_1.pdf
264,2009-05-20,太龙药业股票异常波动公告,/disclosure/listedinfo/announcement/c/2009-05-20/600222_20090520_2.pdf
265,2009-05-20,太龙药业股东出售股票情况的公告,/disclosure/listedinfo/announcement/c/2009-05-20/600222_20090520_1.pdf
266,2009-05-20,太龙药业股东持股简式权益变动报告书,/disclosure/listedinfo/announcement/c/2009-05-20/600222_20090520_3.pdf
267,2009-06-19,太龙药业股票异常波动公告,/disclosure/listedinfo/announcement/c/2009-06-19/600222_20090619_1.pdf
268,2009-07-25,太龙药业关于控股股东部分股权司法拍卖的公告,/disclosure/listedinfo/announcement/c/2009-07-25/600222_20090725_1.pdf
269,2009-07-30,太龙药业关于控股股东部分股权司法拍卖的公告,/disclosure/listedinfo/announcement/c/2009-07-30/600222_20090730_1.pdf
270,2009-08-15,太龙药业关于控股股东部分股权司法拍卖结果的公告,/disclosure/listedinfo/announcement/c/2009-08-15/600222_20090815_1.pdf
271,2009-08-26,太龙药业关于双黄连合剂等产品进入国家基本药物目录的公告,/disclosure/listedinfo/announcement/c/2009-08-26/600222_20090826_2.pdf
272,2009-08-26,太龙药业股改限售流通股上市公告,/disclosure/listedinfo/announcement/c/2009-08-26/600222_20090826_1.pdf
273,2009-08-27,太龙药业半年报摘要,/disclosure/listedinfo/announcement/c/2009-08-27/600222_2009_zzy.pdf
274,2009-08-27,太龙药业半年报,/disclosure/listedinfo/announcement/c/2009-08-27/600222_2009_z.pdf
275,2009-09-19,太龙药业关于公司股东股权过户的公告,/disclosure/listedinfo/announcement/c/2009-09-19/600222_20090919_1.pdf
276,2009-09-22,太龙药业股东出售股票情况的提示公告,/disclosure/listedinfo/announcement/c/2009-09-22/600222_20090922_1.pdf
277,2009-09-22,太龙药业股东持股简式权益变动报告书,/disclosure/listedinfo/announcement/c/2009-09-22/600222_20090922_2.pdf
278,2009-10-31,太龙药业内幕信息知情人员报备制度,/disclosure/listedinfo/announcement/c/2009-10-31/600222_20091031_2.pdf
279,2009-10-31,太龙药业第四届董事会第二十次会议决议的公告,/disclosure/listedinfo/announcement/c/2009-10-31/600222_20091031_1.pdf
280,2009-10-31,太龙药业第三季度季报,/disclosure/listedinfo/announcement/c/2009-10-31/600222_2009_3.pdf
281,2009-11-02,太龙药业股票异常波动公告,/disclosure/listedinfo/announcement/c/2009-11-02/600222_20091102_1.pdf
282,2009-11-27,太龙药业股东出售股票情况的公告,/disclosure/listedinfo/announcement/c/2009-11-27/600222_20091127_1.pdf
283,2009-12-18,太龙药业关于控股股东股权解除质押及部分股权质押的公告,/disclosure/listedinfo/announcement/c/2009-12-18/600222_20091218_1.pdf
284,2010-01-22,太龙药业关于控股股东部分股权解冻及冻结的公告,/disclosure/listedinfo/announcement/c/2010-01-22/600222_20100122_1.pdf
285,2010-01-23,太龙药业股东出售股票情况及股权过户的提示公告,/disclosure/listedinfo/announcement/c/2010-01-23/600222_20100123_1.pdf
286,2010-01-23,太龙药业股东持股简式权益变动报告书,/disclosure/listedinfo/announcement/c/2010-01-23/600222_20100123_2.pdf
287,2010-03-20,太龙药业外部信息使用人管理制度,/disclosure/listedinfo/announcement/c/2010-03-20/600222_20100320_4.pdf
288,2010-03-20,太龙药业年报摘要,/disclosure/listedinfo/announcement/c/2010-03-20/600222_2009_nzy.pdf
289,2010-03-20,太龙药业年报信息披露重大差错责任追究制度,/disclosure/listedinfo/announcement/c/2010-03-20/600222_20100320_6.pdf
290,2010-03-20,太龙药业年报,/disclosure/listedinfo/announcement/c/2010-03-20/600222_2009_n.pdf
291,2010-03-20,太龙药业控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2010-03-20/600222_20100320_3.pdf
292,2010-03-20,太龙药业独立董事年报工作制度,/disclosure/listedinfo/announcement/c/2010-03-20/600222_20100320_5.pdf
293,2010-03-20,太龙药业第四届监事会第十一次会议决议的公告,/disclosure/listedinfo/announcement/c/2010-03-20/600222_20100320_2.pdf
294,2010-03-20,太龙药业第四届董事会第二十一次会议决议的公告暨召开2009年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2010-03-20/600222_20100320_1.pdf
295,2010-03-30,太龙药业2010年第一季度业绩预增的公告,/disclosure/listedinfo/announcement/c/2010-03-30/600222_20100330_1.pdf
296,2010-04-01,太龙药业2009年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-04-01/600222_20100401_1.pdf
297,2010-04-10,太龙药业2009年年度股东大会决议的公告,/disclosure/listedinfo/announcement/c/2010-04-10/600222_20100410_1.pdf
298,2010-04-10,太龙药业2009年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-04-10/600222_20100410_2.pdf
299,2010-04-22,太龙药业第一季度季报,/disclosure/listedinfo/announcement/c/2010-04-22/600222_2010_1.pdf
300,2010-04-22,太龙药业第四届董事会第二十二次会议决议的公告,/disclosure/listedinfo/announcement/c/2010-04-22/600222_20100422_1.pdf
301,2010-05-06,太龙药业2009年度利润分配及资本公积转增股本实施的公告,/disclosure/listedinfo/announcement/c/2010-05-06/600222_20100506_1.pdf
302,2010-07-29,太龙药业股东出售股票情况的公告,/disclosure/listedinfo/announcement/c/2010-07-29/600222_20100729_1.pdf
303,2010-08-12,太龙药业职工代表会议决议的公告,/disclosure/listedinfo/announcement/c/2010-08-12/600222_20100812_3.pdf
304,2010-08-12,太龙药业内幕信息知情人员报备制度,/disclosure/listedinfo/announcement/c/2010-08-12/600222_20100812_5.pdf
305,2010-08-12,太龙药业对外担保的公告,/disclosure/listedinfo/announcement/c/2010-08-12/600222_20100812_4.pdf
306,2010-08-12,太龙药业第四届监事会第十三次会议决议的公告,/disclosure/listedinfo/announcement/c/2010-08-12/600222_20100812_2.pdf
307,2010-08-12,太龙药业第四届董事会第二十三次会议决议的公告暨召开2010年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2010-08-12/600222_20100812_1.pdf
308,2010-08-12,太龙药业半年报摘要,/disclosure/listedinfo/announcement/c/2010-08-12/600222_2010_zzy.pdf
309,2010-08-12,太龙药业半年报,/disclosure/listedinfo/announcement/c/2010-08-12/600222_2010_z.pdf
310,2010-08-17,太龙药业2010年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-08-17/600222_20100817_1.pdf
311,2010-08-28,太龙药业公司章程（2010修订）,/disclosure/listedinfo/announcement/c/2010-08-28/600222_20100828_g.pdf
312,2010-08-28,太龙药业2010年第一次临时股东大会决议的公告,/disclosure/listedinfo/announcement/c/2010-08-28/600222_20100828_1.pdf
313,2010-08-28,太龙药业2010年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-08-28/600222_20100828_2.pdf
314,2010-09-27,太龙药业第五届监事会第一次会议决议的公告,/disclosure/listedinfo/announcement/c/2010-09-27/600222_20100927_2.pdf
315,2010-09-27,太龙药业第五届董事会第一次会议决议的公告,/disclosure/listedinfo/announcement/c/2010-09-27/600222_20100927_1.pdf
316,2010-10-28,太龙药业第三季度季报,/disclosure/listedinfo/announcement/c/2010-10-28/600222_2010_3.pdf
317,2011-03-10,太龙药业股东出售股票情况及股权过户的提示公告,/disclosure/listedinfo/announcement/c/2011-03-10/600222_20110310_1.pdf
318,2011-04-09,太龙药业召开2010年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2011-04-09/600222_20110409_2.pdf
319,2011-04-09,太龙药业年报摘要,/disclosure/listedinfo/announcement/c/2011-04-09/600222_2010_nzy.pdf
320,2011-04-09,太龙药业年报,/disclosure/listedinfo/announcement/c/2011-04-09/600222_2010_n.pdf
321,2011-04-09,太龙药业控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2011-04-09/600222_20110409_5.pdf
322,2011-04-09,太龙药业对外担保的公告,/disclosure/listedinfo/announcement/c/2011-04-09/600222_20110409_3.pdf
323,2011-04-09,太龙药业第五届监事会第三次会议决议的公告,/disclosure/listedinfo/announcement/c/2011-04-09/600222_20110409_4.pdf
324,2011-04-09,太龙药业第五届董事会第三次会议决议的公告,/disclosure/listedinfo/announcement/c/2011-04-09/600222_20110409_1.pdf
325,2011-04-25,太龙药业第一季度季报,/disclosure/listedinfo/announcement/c/2011-04-25/600222_2011_1.pdf
326,2011-04-26,太龙药业2010年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-04-26/600222_20110426_1.pdf
327,2011-04-30,太龙药业公司章程（2011修订）,/disclosure/listedinfo/announcement/c/2011-04-30/600222_20110430_g.pdf
328,2011-04-30,太龙药业2010年年度股东大会决议的公告,/disclosure/listedinfo/announcement/c/2011-04-30/600222_20110430_1.pdf
329,2011-04-30,太龙药业2010年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-04-30/600222_20110430_2.pdf
330,2011-05-14,太龙药业董事会秘书工作制度,/disclosure/listedinfo/announcement/c/2011-05-14/600222_20110514_2.pdf
331,2011-05-14,太龙药业第五届董事会第五次会议决议的公告,/disclosure/listedinfo/announcement/c/2011-05-14/600222_20110514_1.pdf
332,2011-06-01,太龙药业关于获得中国驰名商标的公告,/disclosure/listedinfo/announcement/c/2011-06-01/600222_20110601_1.pdf
333,2011-06-04,太龙药业第五届董事会第六次会议决议的公告,/disclosure/listedinfo/announcement/c/2011-06-04/600222_20110604_1.pdf
334,2011-08-20,太龙药业半年报摘要,/disclosure/listedinfo/announcement/c/2011-08-20/600222_2011_zzy.pdf
335,2011-08-20,太龙药业半年报,/disclosure/listedinfo/announcement/c/2011-08-20/600222_2011_z.pdf
336,2011-09-29,太龙药业第五届董事会第八次会议决议的公告,/disclosure/listedinfo/announcement/c/2011-09-29/600222_20110929_1.pdf
337,2011-10-22,太龙药业第三季度季报,/disclosure/listedinfo/announcement/c/2011-10-22/600222_2011_3.pdf
338,2011-11-16,太龙药业第五届监事会第七次会议决议的公告,/disclosure/listedinfo/announcement/c/2011-11-16/600222_20111116_2.pdf
339,2011-11-16,太龙药业第五届董事会第十次会议决议的公告暨召开2011年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2011-11-16/600222_20111116_1.pdf
340,2011-11-24,太龙药业2011年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-11-24/600222_20111124_1.pdf
341,2011-12-02,太龙药业公司章程（2011修订）,/disclosure/listedinfo/announcement/c/2011-12-02/600222_20111202_g.pdf
342,2011-12-02,太龙药业大容量注射剂项目获得国家GMP证书的公告,/disclosure/listedinfo/announcement/c/2011-12-02/600222_20111202_2.pdf
343,2011-12-02,太龙药业2011年第一次临时股东大会决议的公告,/disclosure/listedinfo/announcement/c/2011-12-02/600222_20111202_1.pdf
344,2011-12-02,太龙药业2011年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-12-02/600222_20111202_3.pdf
345,2012-01-05,太龙药业关于控股股东部分股权续冻的公告,/disclosure/listedinfo/announcement/c/2012-01-05/600222_20120105_1.pdf
346,2012-01-11,太龙药业内幕信息知情人员报备制度,/disclosure/listedinfo/announcement/c/2012-01-11/600222_20120111_2.pdf
347,2012-01-11,太龙药业第五届董事会第十一次会议决议的公告暨召开2012年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2012-01-11/600222_20120111_1.pdf
348,2012-01-18,太龙药业2012年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-01-18/600222_20120118_1.pdf
349,2012-02-03,太龙药业2012年第一次临时股东大会决议的公告,/disclosure/listedinfo/announcement/c/2012-02-03/600222_20120203_1.pdf
350,2012-02-03,太龙药业2012年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-02-03/600222_20120203_2.pdf
351,2012-03-02,太龙药业与郑州铝业股份有限公司互保情况说明的公告,/disclosure/listedinfo/announcement/c/2012-03-02/600222_20120302_3.pdf
352,2012-03-02,太龙药业获得高新技术企业复审证书的公告,/disclosure/listedinfo/announcement/c/2012-03-02/600222_20120302_2.pdf
353,2012-03-02,太龙药业对外投资的公告,/disclosure/listedinfo/announcement/c/2012-03-02/600222_20120302_1.pdf
354,2012-03-31,太龙药业年报摘要,/disclosure/listedinfo/announcement/c/2012-03-31/600222_2011_nzy.pdf
355,2012-03-31,太龙药业年报,/disclosure/listedinfo/announcement/c/2012-03-31/600222_2011_n.pdf
356,2012-03-31,太龙药业内部控制规范实施工作方案,/disclosure/listedinfo/announcement/c/2012-03-31/600222_20120331_7.pdf
357,2012-03-31,太龙药业控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2012-03-31/600222_20120331_5.pdf
358,2012-03-31,太龙药业对外担保的公告,/disclosure/listedinfo/announcement/c/2012-03-31/600222_20120331_3.pdf
359,2012-03-31,太龙药业独立董事2011年度述职报告,/disclosure/listedinfo/announcement/c/2012-03-31/600222_20120331_6.pdf
360,2012-03-31,太龙药业第五届监事会第八次会议决议的公告,/disclosure/listedinfo/announcement/c/2012-03-31/600222_20120331_2.pdf
361,2012-03-31,太龙药业第五届董事会第十二次会议决议的公告,/disclosure/listedinfo/announcement/c/2012-03-31/600222_20120331_1.pdf
362,2012-03-31,太龙药业2012年度非公开发行股票预案,/disclosure/listedinfo/announcement/c/2012-03-31/600222_20120331_4.pdf
363,2012-04-12,太龙药业召开2011年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2012-04-12/600222_20120412_1.pdf
364,2012-04-21,太龙药业第一季度季报,/disclosure/listedinfo/announcement/c/2012-04-21/600222_2012_1.pdf
365,2012-04-27,太龙药业关于2011年年度股东大会延迟召开暨召开2011年年度股东大会提示性的公告,/disclosure/listedinfo/announcement/c/2012-04-27/600222_20120427_1.pdf
366,2012-05-18,太龙药业关于召开2011年年度股东大会第二次提示性公告,/disclosure/listedinfo/announcement/c/2012-05-18/600222_20120518_1.pdf
367,2012-05-18,太龙药业2011年度股东大会材料,/disclosure/listedinfo/announcement/c/2012-05-18/600222_20120518_2.pdf
368,2012-05-26,太龙药业2011年年度股东大会决议的公告,/disclosure/listedinfo/announcement/c/2012-05-26/600222_20120526_1.pdf
369,2012-05-26,太龙药业2011年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-05-26/600222_20120526_2.pdf
370,2012-06-15,太龙药业召开2012年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2012-06-15/600222_20120615_4.pdf
371,2012-06-15,太龙药业未来三年股东回报规划（2012年-2014年）,/disclosure/listedinfo/announcement/c/2012-06-15/600222_20120615_5.pdf
372,2012-06-15,太龙药业关于控股子公司与关联方进行日常关联交易的公告,/disclosure/listedinfo/announcement/c/2012-06-15/600222_20120615_3.pdf
373,2012-06-15,太龙药业第五届董事会第十四次会议决议的公告,/disclosure/listedinfo/announcement/c/2012-06-15/600222_20120615_1.pdf
374,2012-06-15,太龙药业2012年度非公开发行股票预案（修订稿）,/disclosure/listedinfo/announcement/c/2012-06-15/600222_20120615_2.pdf
375,2012-06-27,太龙药业2012年第二次临时股东大会材料,/disclosure/listedinfo/announcement/c/2012-06-27/600222_20120627_1.pdf
376,2012-06-28,太龙药业召开2012年第二次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2012-06-28/600222_20120628_1.pdf
377,2012-07-04,太龙药业2012年第二次临时股东大会决议的公告,/disclosure/listedinfo/announcement/c/2012-07-04/600222_20120704_1.pdf
378,2012-07-04,太龙药业2012年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-07-04/600222_20120704_2.pdf
379,2012-07-14,太龙药业内部控制规范实施进展情况报告,/disclosure/listedinfo/announcement/c/2012-07-14/600222_20120714_1.pdf
380,2012-08-25,太龙药业第五届董事会第十五次会议决议的公告,/disclosure/listedinfo/announcement/c/2012-08-25/600222_20120825_1.pdf
381,2012-08-25,太龙药业半年报摘要,/disclosure/listedinfo/announcement/c/2012-08-25/600222_2012_zzy.pdf
382,2012-08-25,太龙药业半年报,/disclosure/listedinfo/announcement/c/2012-08-25/600222_2012_z.pdf
383,2012-09-05,太龙药业第五届董事会第十六次会议决议的公告暨召开2012年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2012-09-05/600222_20120905_1.pdf
384,2012-09-15,太龙药业2012年第三次临时股东大会材料,/disclosure/listedinfo/announcement/c/2012-09-15/600222_20120915_1.pdf
385,2012-09-21,太龙药业2012年第三次临时股东大会决议的公告,/disclosure/listedinfo/announcement/c/2012-09-21/600222_20120921_1.pdf
386,2012-09-21,太龙药业2012年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-09-21/600222_20120921_2.pdf
387,2012-10-26,太龙药业第三季度季报,/disclosure/listedinfo/announcement/c/2012-10-26/600222_2012_3.pdf
388,2012-12-21,太龙药业控股子公司参股股东的控股股东变更的公告,/disclosure/listedinfo/announcement/c/2012-12-21/600222_20121221_2.pdf
389,2012-12-21,太龙药业关于最近五年被证券监管部门和交易所采取监管措施或处罚及整改情况的公告,/disclosure/listedinfo/announcement/c/2012-12-21/600222_20121221_1.pdf
390,2013-01-21,太龙药业2012年年度业绩预增公告,/disclosure/listedinfo/announcement/c/2013-01-20/600222_20130121_1.pdf
391,2013-01-25,太龙药业2012年度业绩快报公告,/disclosure/listedinfo/announcement/c/2013-01-24/600222_20130125_1.pdf
392,2013-02-04,太龙药业关于非公开发行股票申请获得中国证监会发行审核委员会审核通过的公告,/disclosure/listedinfo/announcement/c/2013-02-03/600222_20130204_1.pdf
393,2013-03-08,太龙药业关于非公开发行股票申请获得中国证监会核准的公告,/disclosure/listedinfo/announcement/c/2013-03-07/600222_20130308_1.pdf
394,2013-04-13,太龙药业召开2012年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2013-04-12/600222_20130413_5.pdf
395,2013-04-13,太龙药业年报摘要,/disclosure/listedinfo/announcement/c/2013-04-12/600222_2012_nzy.pdf
396,2013-04-13,太龙药业年报,/disclosure/listedinfo/announcement/c/2013-04-12/600222_2012_n.pdf
397,2013-04-13,太龙药业控股股东及其他关联方占用资金情况的专项说明,/disclosure/listedinfo/announcement/c/2013-04-12/600222_20130413_10.pdf
398,2013-04-13,太龙药业关于2012年度日常关联交易情况及预计2013年度公司及控股子公司与关联方进行日常关联交易事前认可的意见,/disclosure/listedinfo/announcement/c/2013-04-12/600222_20130413_12.pdf
399,2013-04-13,太龙药业关于2012年度日常关联交易情况及预计2013年度公司及控股子公司与关联方进行日常关联交易的公告,/disclosure/listedinfo/announcement/c/2013-04-12/600222_20130413_3.pdf
400,2013-04-13,太龙药业对外担保的公告,/disclosure/listedinfo/announcement/c/2013-04-12/600222_20130413_4.pdf
401,2013-04-13,太龙药业独立董事关于公司第五届董事会第十八次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2013-04-12/600222_20130413_14.pdf
402,2013-04-13,太龙药业独立董事2012年度述职报告,/disclosure/listedinfo/announcement/c/2013-04-12/600222_20130413_11.pdf
403,2013-04-13,太龙药业独立董事2012年度日常关联交易情况及2013年度公司及控股子公司与关联方进行日常关联交易事前认可的意见签字页,/disclosure/listedinfo/announcement/c/2013-04-12/600222_20130413_13.pdf
404,2013-04-13,太龙药业第五届监事会第八次会议决议的公告,/disclosure/listedinfo/announcement/c/2013-04-12/600222_20130413_6.pdf
405,2013-04-13,太龙药业第五届董事会第十八次会议决议的公告,/disclosure/listedinfo/announcement/c/2013-04-12/600222_20130413_2.pdf
406,2013-04-13,太龙药业2012年度财务报表审计报告,/disclosure/listedinfo/announcement/c/2013-04-12/600222_20130413_9.pdf
407,2013-04-25,太龙药业第一季度季报,/disclosure/listedinfo/announcement/c/2013-04-24/600222_2013_1.pdf
408,2013-04-27,太龙药业关于召开2012年度现金分红专项说明会的通知暨公司非公开发行保荐人联系方式变更的公告,/disclosure/listedinfo/announcement/c/2013-04-26/600222_20130427_1.pdf
409,2013-05-03,太龙药业2012年年度股东大会会议材料,/disclosure/listedinfo/announcement/c/2013-05-02/600222_20130503_1.pdf
410,2013-05-03,太龙药业2012年度现金分红专项说明会召开情况的公告,/disclosure/listedinfo/announcement/c/2013-05-02/600222_20130503_2.pdf
411,2013-05-03,太龙药业2012年度现金分红专项说明会会议纪要,/disclosure/listedinfo/announcement/c/2013-05-02/600222_20130503_3.pdf
412,2013-05-11,太龙药业2012年年度股东大会决议的公告,/disclosure/listedinfo/announcement/c/2013-05-10/600222_20130511_1.pdf
413,2013-05-11,太龙药业2012年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-05-10/600222_20130511_2.pdf
414,2013-06-18,太龙药业与浙江大学签订现代中药创制战略合作协议的公告,/disclosure/listedinfo/announcement/c/2013-06-17/600222_20130618_1.pdf
415,2013-07-12,太龙药业2013年半年度业绩预增的公告,/disclosure/listedinfo/announcement/c/2013-07-11/600222_20130712_1.pdf
416,2013-07-19,太龙药业关于收购资产及对外投资的公告,/disclosure/listedinfo/announcement/c/2013-07-18/600222_20130719_2.pdf
417,2013-07-19,太龙药业第五届董事会第二十次会议决议的公告,/disclosure/listedinfo/announcement/c/2013-07-18/600222_20130719_1.pdf
418,2013-08-01,太龙药业验资报告,/disclosure/listedinfo/announcement/c/2013-07-31/600222_20130801_6.pdf
419,2013-08-01,太龙药业简式权益变动报告书,/disclosure/listedinfo/announcement/c/2013-07-31/600222_20130801_2.pdf
420,2013-08-01,太龙药业非公开发行股票之发行过程和认购对象合规性的法律意见书,/disclosure/listedinfo/announcement/c/2013-07-31/600222_20130801_4.pdf
421,2013-08-01,太龙药业非公开发行股票发行情况报告书,/disclosure/listedinfo/announcement/c/2013-07-31/600222_20130801_5.pdf
422,2013-08-01,太龙药业非公开发行股票发行结果暨股本变动公告,/disclosure/listedinfo/announcement/c/2013-07-31/600222_20130801_1.pdf
423,2013-08-01,太龙药业非公开发行股票发行过程及发行对象合规性之审核报告,/disclosure/listedinfo/announcement/c/2013-07-31/600222_20130801_3.pdf
424,2013-08-06,太龙药业职工代表大会决议的公告,/disclosure/listedinfo/announcement/c/2013-08-05/600222_20130806_5.pdf
425,2013-08-06,太龙药业关于召开2013年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2013-08-05/600222_20130806_3.pdf
426,2013-08-06,太龙药业关于公司章程修正案的公告,/disclosure/listedinfo/announcement/c/2013-08-05/600222_20130806_2.pdf
427,2013-08-06,太龙药业独立董事提名人声明,/disclosure/listedinfo/announcement/c/2013-08-05/600222_20130806_7.pdf
428,2013-08-06,太龙药业独立董事候选人声明,/disclosure/listedinfo/announcement/c/2013-08-05/600222_20130806_9.pdf
429,2013-08-06,太龙药业独立董事候选人声明,/disclosure/listedinfo/announcement/c/2013-08-05/600222_20130806_10.pdf
430,2013-08-06,太龙药业独立董事候选人声明,/disclosure/listedinfo/announcement/c/2013-08-05/600222_20130806_8.pdf
431,2013-08-06,太龙药业独立董事对调整公司董事会成员人数及换届选举事项发表独立意见,/disclosure/listedinfo/announcement/c/2013-08-05/600222_20130806_6.pdf
432,2013-08-06,太龙药业第五届监事会第十四次会议决议的公告,/disclosure/listedinfo/announcement/c/2013-08-05/600222_20130806_4.pdf
433,2013-08-06,太龙药业第五届董事会第二十一次会议决议的公告,/disclosure/listedinfo/announcement/c/2013-08-05/600222_20130806_1.pdf
434,2013-08-12,太龙药业半年报摘要,/disclosure/listedinfo/announcement/c/2013-08-11/600222_2013_zzy.pdf
435,2013-08-12,太龙药业半年报,/disclosure/listedinfo/announcement/c/2013-08-11/600222_2013_z.pdf
436,2013-08-14,太龙药业关于签订募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2013-08-13/600222_20130814_2.pdf
437,2013-08-14,太龙药业非金融企业债务融资工具信息披露事务管理制度,/disclosure/listedinfo/announcement/c/2013-08-13/600222_20130814_3.pdf
438,2013-08-14,太龙药业第五届董事会第二十三次会议决议的公告,/disclosure/listedinfo/announcement/c/2013-08-13/600222_20130814_1.pdf
439,2013-08-15,太龙药业2013年第一次临时股东大会会议材料,/disclosure/listedinfo/announcement/c/2013-08-14/600222_20130815_1.pdf
440,2013-08-16,太龙药业2013年半年报更正的公告,/disclosure/listedinfo/announcement/c/2013-08-15/600222_20130816_1.pdf
441,2013-08-22,太龙药业使用闲置募集资金暂时补充流动资金的核查意见,/disclosure/listedinfo/announcement/c/2013-08-21/600222_20130822_8.pdf
442,2013-08-22,太龙药业募集资金管理办法,/disclosure/listedinfo/announcement/c/2013-08-21/600222_20130822_10.pdf
443,2013-08-22,太龙药业关于使用闲置募集资金暂时补充流动资金的公告,/disclosure/listedinfo/announcement/c/2013-08-21/600222_20130822_5.pdf
444,2013-08-22,太龙药业关于申请发行短期融资券的公告,/disclosure/listedinfo/announcement/c/2013-08-21/600222_20130822_2.pdf
445,2013-08-22,太龙药业公司章程（2013修订）,/disclosure/listedinfo/announcement/c/2013-08-21/600222_20130822_9.pdf
446,2013-08-22,太龙药业独立董事意见,/disclosure/listedinfo/announcement/c/2013-08-21/600222_20130822_7.pdf
447,2013-08-22,太龙药业第六届监事会第一次会议决议的公告,/disclosure/listedinfo/announcement/c/2013-08-21/600222_20130822_4.pdf
448,2013-08-22,太龙药业第六届董事会第一次会议决议的公告,/disclosure/listedinfo/announcement/c/2013-08-21/600222_20130822_3.pdf
449,2013-08-22,太龙药业2013年第一次临时股东大会决议的公告,/disclosure/listedinfo/announcement/c/2013-08-21/600222_20130822_1.pdf
450,2013-08-22,太龙药业2013年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-08-21/600222_20130822_6.pdf
451,2013-09-17,太龙药业与北京民康百草医药科技有限公司签订技术转让合同的公告,/disclosure/listedinfo/announcement/c/2013-09-16/600222_20130917_2.pdf
452,2013-09-17,太龙药业对外担保的公告,/disclosure/listedinfo/announcement/c/2013-09-16/600222_20130917_3.pdf
453,2013-09-17,太龙药业第六届董事会第二次会议决议的公告,/disclosure/listedinfo/announcement/c/2013-09-16/600222_20130917_1.pdf
454,2013-09-17,太龙药业：关于签订信贷互保相关事项的独立意见,/disclosure/listedinfo/announcement/c/2013-09-16/600222_20130917_4.pdf
455,2013-10-16,太龙药业业绩预增公告,/disclosure/listedinfo/announcement/c/2013-10-15/600222_20131016_1.pdf
456,2013-10-26,太龙药业关于召开2013年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2013-10-25/600222_20131026_6.pdf
457,2013-10-26,太龙药业关于增加预计2013年度公司及控股子公司与关联方进行日常关联交易总额的公告,/disclosure/listedinfo/announcement/c/2013-10-25/600222_20131026_5.pdf
458,2013-10-26,太龙药业第三季度季报,/disclosure/listedinfo/announcement/c/2013-10-25/600222_2013_3.pdf
459,2013-10-26,太龙药业第六届监事会第二次会议决议的公告,/disclosure/listedinfo/announcement/c/2013-10-25/600222_20131026_4.pdf
460,2013-10-26,太龙药业第六届董事会第三次会议决议的公告,/disclosure/listedinfo/announcement/c/2013-10-25/600222_20131026_3.pdf
461,2013-11-01,太龙药业以自筹资金预先投入募投项目的鉴证报告,/disclosure/listedinfo/announcement/c/2013-10-31/600222_20131101_2.pdf
462,2013-11-01,太龙药业以募集资金置换预先投入募投项目自筹资金的核查意见,/disclosure/listedinfo/announcement/c/2013-10-31/600222_20131101_3.pdf
463,2013-11-01,太龙药业关于以募集资金置换预先投入自筹资金的公告,/disclosure/listedinfo/announcement/c/2013-10-31/600222_20131101_1.pdf
464,2013-11-06,太龙药业2013年第二次临时股东大会会议材料,/disclosure/listedinfo/announcement/c/2013-11-05/600222_20131106_1.pdf
465,2013-11-14,太龙药业2013年第二次临时股东大会决议的公告,/disclosure/listedinfo/announcement/c/2013-11-13/600222_20131114_1.pdf
466,2013-11-14,太龙药业2013年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-11-13/600222_20131114_2.pdf
467,2013-12-07,太龙药业关于控股股东拟增持股份的公告,/disclosure/listedinfo/announcement/c/2013-12-06/600222_20131207_1.pdf
468,2013-12-21,太龙药业关于完成子公司收购及增资的工商注册变更的公告,/disclosure/listedinfo/announcement/c/2013-12-20/600222_20131221_1.pdf
469,2013-12-21,太龙药业关于发行短期融资券申请获得注册的公告,/disclosure/listedinfo/announcement/c/2013-12-20/600222_20131221_2.pdf
470,2013-12-30,太龙药业关于投资设立控股子公司的公告,/disclosure/listedinfo/announcement/c/2013-12-29/600222_20131230_1.pdf
471,2014-01-15,太龙药业业绩预增公告,/disclosure/listedinfo/announcement/c/2014-01-14/600222_20140115_2.pdf
472,2014-01-15,太龙药业关于将部分闲置募集资金转为定期存款存放的公告,/disclosure/listedinfo/announcement/c/2014-01-14/600222_20140115_1.pdf
473,2014-02-15,太龙药业关于承诺相关方承诺履行情况的公告,/disclosure/listedinfo/announcement/c/2014-02-14/600222_20140215_1.pdf
474,2014-02-15,太龙药业2014年度第一期短期融资券发行情况公告,/disclosure/listedinfo/announcement/c/2014-02-14/600222_20140215_2.pdf
475,2014-02-18,太龙药业关于子公司郑州杏林园艺开发有限公司完成工商设立登记的公告,/disclosure/listedinfo/announcement/c/2014-02-17/600222_20140218_1.pdf
476,2014-02-22,太龙药业关于所聘会计师事务所名称变更的公告,/disclosure/listedinfo/announcement/c/2014-02-21/600222_20140222_1.pdf
477,2014-03-24,太龙药业年报摘要,/disclosure/listedinfo/announcement/c/2014-03-23/600222_2013_nzy.pdf
478,2014-03-24,太龙药业年报,/disclosure/listedinfo/announcement/c/2014-03-23/600222_2013_n.pdf
479,2014-03-24,太龙药业关于召开2013年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2014-03-23/600222_20140324_8.pdf
480,2014-03-24,太龙药业关于预计2014年度公司及控股子公司与关联方进行日常关联交易的公告,/disclosure/listedinfo/announcement/c/2014-03-23/600222_20140324_6.pdf
481,2014-03-24,太龙药业关于部分募集资金投资项目实施地点变更的公告,/disclosure/listedinfo/announcement/c/2014-03-23/600222_20140324_7.pdf
482,2014-03-24,太龙药业独立董事关于公司第六届董事会第六次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2014-03-23/600222_20140324_20.pdf
483,2014-03-24,太龙药业独立董事对公司对外担保情况的专项说明,/disclosure/listedinfo/announcement/c/2014-03-23/600222_20140324_11.pdf
484,2014-03-24,太龙药业独立董事2013年度述职报告,/disclosure/listedinfo/announcement/c/2014-03-23/600222_20140324_14.pdf
485,2014-03-24,太龙药业第六届监事会第四次会议决议的公告,/disclosure/listedinfo/announcement/c/2014-03-23/600222_20140324_5.pdf
486,2014-03-24,太龙药业第六届董事会第六次会议决议的公告,/disclosure/listedinfo/announcement/c/2014-03-23/600222_20140324_4.pdf
487,2014-03-24,太龙药业：恒泰证券股份有限公司关于河南太龙药业股份有限公司关联交易的核查意见,/disclosure/listedinfo/announcement/c/2014-03-23/600222_20140324_21.pdf
488,2014-03-24,太龙药业：恒泰证券股份有限公司关于河南太龙药业股份有限公司非公开发行股票募集资金投资项目相关事项的核查意见,/disclosure/listedinfo/announcement/c/2014-03-23/600222_20140324_22.pdf
489,2014-03-24,太龙药业：恒泰证券股份有限公司关于河南太龙药业股份有限公司2013年度募集资金存放与使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2014-03-23/600222_20140324_17.pdf
490,2014-03-24,太龙药业：恒泰证券股份有限公司关于河南太龙药业股份有限公司2013年度募集资金存放与使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2014-03-23/600222_20140324_23.pdf
491,2014-03-24,太龙药业：恒泰证券股份有限公司关于河南太龙药业股份有限公司2013年度持续督导报告书,/disclosure/listedinfo/announcement/c/2014-03-23/600222_20140324_3.pdf
492,2014-03-24,太龙药业：关于河南太龙药业股份有限公司控股股东及其他关联方占用资金情况的专项说明,/disclosure/listedinfo/announcement/c/2014-03-23/600222_20140324_13.pdf
493,2014-03-24,太龙药业：关于河南太龙药业股份有限公司2013年度募集资金存放与使用情况的鉴证报告,/disclosure/listedinfo/announcement/c/2014-03-23/600222_20140324_15.pdf
494,2014-03-24,太龙药业：关于河南太龙药业股份有限公司2013年度募集资金存放与使用情况的鉴证报告,/disclosure/listedinfo/announcement/c/2014-03-23/600222_20140324_24.pdf
495,2014-03-24,太龙药业：关于河南太龙药业股份有限公司2013年度募集资金存放与使用情况的鉴证报告,/disclosure/listedinfo/announcement/c/2014-03-23/600222_20140324_16.pdf
496,2014-03-24,太龙药业2013年度募集资金存放与使用情况专项报告,/disclosure/listedinfo/announcement/c/2014-03-23/600222_20140324_9.pdf
497,2014-03-24,太龙药业2013年度董事会审计委员会述职报告,/disclosure/listedinfo/announcement/c/2014-03-23/600222_20140324_19.pdf
498,2014-03-24,太龙药业2013年度财务报表审计报告,/disclosure/listedinfo/announcement/c/2014-03-23/600222_20140324_12.pdf
499,2014-03-25,太龙药业关于召开2013年年度股东大会通知的补充公告,/disclosure/listedinfo/announcement/c/2014-03-24/600222_20140325_1.pdf
500,2014-03-26,太龙药业第六届董事会第七次会议决议的公告,/disclosure/listedinfo/announcement/c/2014-03-25/600222_20140326_1.pdf
501,2014-04-10,太龙药业2013年年度股东大会会议材料,/disclosure/listedinfo/announcement/c/2014-04-09/600222_20140410_1.pdf
502,2014-04-17,太龙药业2013年年度股东大会决议的公告,/disclosure/listedinfo/announcement/c/2014-04-16/600222_20140417_1.pdf
503,2014-04-17,太龙药业2013年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-04-16/600222_20140417_2.pdf
504,2014-04-26,太龙药业关于使用暂时闲置的募集资金购买保本型理财产品的公告,/disclosure/listedinfo/announcement/c/2014-04-25/600222_20140426_4.pdf
505,2014-04-26,太龙药业第一季度季报,/disclosure/listedinfo/announcement/c/2014-04-25/600222_2014_1.pdf
506,2014-04-26,太龙药业第六届监事会第五次会议决议的公告,/disclosure/listedinfo/announcement/c/2014-04-25/600222_20140426_3.pdf
507,2014-04-26,太龙药业第六届董事会第八次会议决议的公告,/disclosure/listedinfo/announcement/c/2014-04-25/600222_20140426_2.pdf
508,2014-04-26,太龙药业：恒泰证券股份有限公司关于河南太龙药业股份有限公司拟利用闲置募集资金购买保本型理财产品的核查意见,/disclosure/listedinfo/announcement/c/2014-04-25/600222_20140426_7.pdf
509,2014-05-01,太龙药业重大事项停牌公告,/disclosure/listedinfo/announcement/c/2014-04-30/600222_20140501_1.pdf
510,2014-05-12,太龙药业资产重组停牌公告,/disclosure/listedinfo/announcement/c/2014-05-11/600222_20140512_1.pdf
511,2014-05-16,太龙药业关于使用暂时闲置募集资金购买银行理财产品实施情况的公告,/disclosure/listedinfo/announcement/c/2014-05-15/600222_20140516_1.pdf
512,2014-05-19,太龙药业资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-05-18/600222_20140519_1.pdf
513,2014-05-26,太龙药业资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-05-25/600222_20140526_1.pdf
514,2014-05-31,太龙药业资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-05-30/600222_20140531_1.pdf
515,2014-05-31,太龙药业关于举办2013年度业绩说明会暨投资者网上集体接待日的公告,/disclosure/listedinfo/announcement/c/2014-05-30/600222_20140531_2.pdf
516,2014-06-04,太龙药业资产重组延期复牌公告,/disclosure/listedinfo/announcement/c/2014-06-03/600222_20140604_1.pdf
517,2014-06-09,太龙药业2013年度分红派息实施的公告,/disclosure/listedinfo/announcement/c/2014-06-08/600222_20140609_1.pdf
518,2014-06-10,太龙药业章程修正案公告,/disclosure/listedinfo/announcement/c/2014-06-09/600222_20140610_4.pdf
519,2014-06-10,太龙药业关于召开2014年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2014-06-09/600222_20140610_5.pdf
520,2014-06-10,太龙药业公司章程（2014修订）,/disclosure/listedinfo/announcement/c/2014-06-09/600222_20140610_9.pdf
521,2014-06-10,太龙药业对控股子公司实施增资的关联交易公告,/disclosure/listedinfo/announcement/c/2014-06-09/600222_20140610_3.pdf
522,2014-06-10,太龙药业独立董事“关于对公司控股子公司进行增资的关联交易的议案”的独立意见,/disclosure/listedinfo/announcement/c/2014-06-09/600222_20140610_6.pdf
523,2014-06-10,太龙药业第六届监事会第六次会议决议的公告,/disclosure/listedinfo/announcement/c/2014-06-09/600222_20140610_2.pdf
524,2014-06-10,太龙药业第六届董事会第九次会议决议的公告,/disclosure/listedinfo/announcement/c/2014-06-09/600222_20140610_1.pdf
525,2014-06-10,太龙药业：桐庐县医药药材有限公司拟以其所拥有的部分资产对河南太龙药业股份有限公司控股子公司杭州桐君堂医药药材有限公司进行增资项目评估报告,/disclosure/listedinfo/announcement/c/2014-06-09/600222_20140610_7.pdf
526,2014-06-10,太龙药业：恒泰证券股份有限公司关于河南太龙药业股份有限公司关联交易的核查意见,/disclosure/listedinfo/announcement/c/2014-06-09/600222_20140610_8.pdf
527,2014-06-11,太龙药业资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-06-10/600222_20140611_1.pdf
528,2014-06-14,太龙药业对控股子公司实施增资的关联交易的补充公告,/disclosure/listedinfo/announcement/c/2014-06-13/600222_20140614_1.pdf
529,2014-06-18,太龙药业资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-06-17/600222_20140618_1.pdf
530,2014-06-19,太龙药业2014年第一次临时股东大会会议材料,/disclosure/listedinfo/announcement/c/2014-06-18/600222_20140619_1.pdf
531,2014-06-20,太龙药业关于使用暂时闲置募集资金购买银行理财产品实施情况的公告,/disclosure/listedinfo/announcement/c/2014-06-19/600222_20140620_1.pdf
532,2014-06-21,太龙药业关于使用暂时闲置募集资金购买银行理财产品实施情况的公告,/disclosure/listedinfo/announcement/c/2014-06-20/600222_20140621_1.pdf
533,2014-06-25,太龙药业资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-06-24/600222_20140625_1.pdf
534,2014-06-26,太龙药业2014年第一次临时股东大会决议的公告,/disclosure/listedinfo/announcement/c/2014-06-25/600222_20140626_1.pdf
535,2014-06-26,太龙药业2014年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-06-25/600222_20140626_2.pdf
536,2014-06-27,太龙药业关于使用暂时闲置募集资金购买银行理财产品实施情况的公告,/disclosure/listedinfo/announcement/c/2014-06-26/600222_20140627_1.pdf
537,2014-07-02,太龙药业资产重组进展及延期复牌的公告,/disclosure/listedinfo/announcement/c/2014-07-01/600222_20140702_1.pdf
538,2014-07-02,太龙药业关于变更持续督导保荐机构的公告,/disclosure/listedinfo/announcement/c/2014-07-01/600222_20140702_2.pdf
539,2014-07-09,太龙药业资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-07-08/600222_20140709_1.pdf
540,2014-07-16,太龙药业资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-07-15/600222_20140716_1.pdf
541,2014-07-16,太龙药业非公开发行限售股上市流通公告,/disclosure/listedinfo/announcement/c/2014-07-15/600222_20140716_2.pdf
542,2014-07-16,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司非公开发行限售股上市流通的核查意见,/disclosure/listedinfo/announcement/c/2014-07-15/600222_20140716_3.pdf
543,2014-07-23,太龙药业资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-07-22/600222_20140723_1.pdf
544,2014-07-30,太龙药业资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-07-29/600222_20140730_1.pdf
545,2014-08-06,太龙药业资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-08-05/600222_20140806_1.pdf
546,2014-08-08,太龙药业资产重组复牌公告,/disclosure/listedinfo/announcement/c/2014-08-07/600222_20140808_2.pdf
547,2014-08-08,太龙药业简式权益变动报告书,/disclosure/listedinfo/announcement/c/2014-08-07/600222_20140808_4.pdf
548,2014-08-08,太龙药业发行股份及支付现金购买资产并募集配套资金暨关联交易预案（摘要）,/disclosure/listedinfo/announcement/c/2014-08-07/600222_20140808_3.pdf
549,2014-08-08,太龙药业发行股份及支付现金购买资产并募集配套资金暨关联交易预案,/disclosure/listedinfo/announcement/c/2014-08-07/600222_20140808_5.pdf
550,2014-08-08,太龙药业独立董事关于公司发行股份及支付现金购买资产并募集配套资金暨关联交易相关事宜的独立意见,/disclosure/listedinfo/announcement/c/2014-08-07/600222_20140808_6.pdf
551,2014-08-08,太龙药业第六届董事会第十次会议决议的公告,/disclosure/listedinfo/announcement/c/2014-08-07/600222_20140808_1.pdf
552,2014-08-08,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司股票价格波动是否达到《关于规范上市公司信息披露及相关各方行为的通知》第五条相关标准的核查意见,/disclosure/listedinfo/announcement/c/2014-08-07/600222_20140808_8.pdf
553,2014-08-08,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易预案之独立财务顾问核查意见,/disclosure/listedinfo/announcement/c/2014-08-07/600222_20140808_7.pdf
554,2014-08-23,太龙药业关于闲置募集资金暂时补充流动资金到期归还的公告,/disclosure/listedinfo/announcement/c/2014-08-22/600222_20140823_5.pdf
555,2014-08-23,太龙药业第六届监事会第七次会议决议的公告,/disclosure/listedinfo/announcement/c/2014-08-22/600222_20140823_3.pdf
556,2014-08-23,太龙药业第六届董事会第十一次会议决议的公告,/disclosure/listedinfo/announcement/c/2014-08-22/600222_20140823_2.pdf
557,2014-08-23,太龙药业半年报摘要,/disclosure/listedinfo/announcement/c/2014-08-22/600222_2014_zzy.pdf
558,2014-08-23,太龙药业半年报,/disclosure/listedinfo/announcement/c/2014-08-22/600222_2014_z.pdf
559,2014-08-23,太龙药业2014年半年度审计报告,/disclosure/listedinfo/announcement/c/2014-08-22/600222_20140823_7.pdf
560,2014-08-23,太龙药业2014年半年度募集资金存放与使用情况专项报告,/disclosure/listedinfo/announcement/c/2014-08-22/600222_20140823_4.pdf
561,2014-09-06,太龙药业召开2014年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2014-09-05/600222_20140906_2.pdf
562,2014-09-06,太龙药业拟收购杭州桐君堂医药药材有限公司49%股权项目评估报告,/disclosure/listedinfo/announcement/c/2014-09-05/600222_20140906_7.pdf
563,2014-09-06,太龙药业拟收购北京新领先医药科技发展有限公司股权项目评估报告,/disclosure/listedinfo/announcement/c/2014-09-05/600222_20140906_12.pdf
564,2014-09-06,太龙药业发行股份及支付现金购买资产并募集配套资金暨关联交易报告书（草案）摘要,/disclosure/listedinfo/announcement/c/2014-09-05/600222_20140906_3.pdf
565,2014-09-06,太龙药业发行股份及支付现金购买资产并募集配套资金暨关联交易报告书（草案）,/disclosure/listedinfo/announcement/c/2014-09-05/600222_20140906_4.pdf
566,2014-09-06,太龙药业独立董事关于评估机构的独立性、评估假设前提的合理性、评估方法与评估目的相关性以及评估定价公允性的独立意见,/disclosure/listedinfo/announcement/c/2014-09-05/600222_20140906_16.pdf
567,2014-09-06,太龙药业独立董事关于公司发行股份及支付现金购买资产并募集配套资金暨关联交易相关事宜的独立意见,/disclosure/listedinfo/announcement/c/2014-09-05/600222_20140906_17.pdf
568,2014-09-06,太龙药业第六届董事会第十二次会议决议的公告,/disclosure/listedinfo/announcement/c/2014-09-05/600222_20140906_1.pdf
569,2014-09-06,太龙药业财务报表审计报告,/disclosure/listedinfo/announcement/c/2014-09-05/600222_20140906_6.pdf
570,2014-09-06,太龙药业备考合并盈利预测审核报告,/disclosure/listedinfo/announcement/c/2014-09-05/600222_20140906_9.pdf
571,2014-09-06,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易报告书（草案）之独立财务顾问报告,/disclosure/listedinfo/announcement/c/2014-09-05/600222_20140906_5.pdf
572,2014-09-06,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司发行股份及支付现金购买资产并募集配套资金涉及关联交易的核查意见,/disclosure/listedinfo/announcement/c/2014-09-05/600222_20140906_15.pdf
573,2014-09-06,太龙药业：河南仟问律师事务所关于河南太龙药业股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易的法律意见书,/disclosure/listedinfo/announcement/c/2014-09-05/600222_20140906_8.pdf
574,2014-09-06,太龙药业：杭州桐君堂医药药材有限公司合并盈利预测审核报告,/disclosure/listedinfo/announcement/c/2014-09-05/600222_20140906_13.pdf
575,2014-09-06,太龙药业：杭州桐君堂医药药材有限公司2012年度、2013年度、2014年1-6月财务报表审计报告,/disclosure/listedinfo/announcement/c/2014-09-05/600222_20140906_10.pdf
576,2014-09-06,太龙药业：北京新领先医药科技发展有限公司合并盈利预测审核报告,/disclosure/listedinfo/announcement/c/2014-09-05/600222_20140906_14.pdf
577,2014-09-06,太龙药业：北京新领先医药科技发展有限公司2012年度、2013年度及2014年1-6月财务报表审计报告,/disclosure/listedinfo/announcement/c/2014-09-05/600222_20140906_11.pdf
578,2014-09-16,太龙药业2014年第二次临时股东大会会议材料,/disclosure/listedinfo/announcement/c/2014-09-15/600222_20140916_1.pdf
579,2014-09-18,太龙药业关于独立董事辞职的公告,/disclosure/listedinfo/announcement/c/2014-09-17/600222_20140918_2.pdf
580,2014-09-18,太龙药业2014年第二次临时股东大会延期召开公告,/disclosure/listedinfo/announcement/c/2014-09-17/600222_20140918_1.pdf
581,2014-09-26,太龙药业关于使用暂时闲置募集资金购买银行理财产品实施情况的公告,/disclosure/listedinfo/announcement/c/2014-09-25/600222_20140926_1.pdf
582,2014-10-14,太龙药业关于收到国资委批复文件的提示性公告,/disclosure/listedinfo/announcement/c/2014-10-13/600222_20141014_1.pdf
583,2014-10-14,太龙药业2014年第二次临时股东大会决议的公告,/disclosure/listedinfo/announcement/c/2014-10-13/600222_20141014_2.pdf
584,2014-10-14,太龙药业2014年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-10-13/600222_20141014_3.pdf
585,2014-10-24,太龙药业关于本次资产重组申请材料获得中国证监会行政许可申请受理的公告,/disclosure/listedinfo/announcement/c/2014-10-23/600222_20141024_1.pdf
586,2014-10-25,太龙药业关于会计政策变更的公告,/disclosure/listedinfo/announcement/c/2014-10-24/600222_20141025_5.pdf
587,2014-10-25,太龙药业对外投资的公告,/disclosure/listedinfo/announcement/c/2014-10-24/600222_20141025_4.pdf
588,2014-10-25,太龙药业第三季度季报,/disclosure/listedinfo/announcement/c/2014-10-24/600222_2014_3.pdf
589,2014-10-25,太龙药业第六届监事会第八次会议决议的公告,/disclosure/listedinfo/announcement/c/2014-10-24/600222_20141025_3.pdf
590,2014-10-25,太龙药业第六届董事会第十三次会议决议的公告,/disclosure/listedinfo/announcement/c/2014-10-24/600222_20141025_2.pdf
591,2014-10-28,太龙药业简式权益变动报告书,/disclosure/listedinfo/announcement/c/2014-10-27/600222_20141028_2.pdf
592,2014-10-28,太龙药业关于持股5%以上股东减持股份的提示性公告,/disclosure/listedinfo/announcement/c/2014-10-27/600222_20141028_1.pdf
593,2014-12-23,太龙药业关于使用暂时闲置募集资金购买银行理财产品实施情况的公告,/disclosure/listedinfo/announcement/c/2014-12-22/600222_20141223_1.pdf
594,2014-12-25,太龙药业关于使用暂时闲置募集资金购买银行理财产品实施情况的公告,/disclosure/listedinfo/announcement/c/2014-12-24/600222_20141225_1.pdf
595,2014-12-27,太龙药业拟与江西施美制药有限公司签订技术转让合同的公告,/disclosure/listedinfo/announcement/c/2014-12-26/600222_20141227_8.pdf
596,2014-12-27,太龙药业关于为控股子公司提供担保的公告,/disclosure/listedinfo/announcement/c/2014-12-26/600222_20141227_5.pdf
597,2014-12-27,太龙药业关于投资设立全资子公司的公告,/disclosure/listedinfo/announcement/c/2014-12-26/600222_20141227_4.pdf
598,2014-12-27,太龙药业关于使用闲置募集资金暂时补充流动资金的公告,/disclosure/listedinfo/announcement/c/2014-12-26/600222_20141227_6.pdf
599,2014-12-27,太龙药业关于全资子公司整体收购分公司的方案公告,/disclosure/listedinfo/announcement/c/2014-12-26/600222_20141227_3.pdf
600,2014-12-27,太龙药业关于公司独立董事变更的公告,/disclosure/listedinfo/announcement/c/2014-12-26/600222_20141227_7.pdf
601,2014-12-27,太龙药业独立董事意见,/disclosure/listedinfo/announcement/c/2014-12-26/600222_20141227_9.pdf
602,2014-12-27,太龙药业独立董事提名人声明,/disclosure/listedinfo/announcement/c/2014-12-26/600222_20141227_12.pdf
603,2014-12-27,太龙药业独立董事候选人声明（张复生）,/disclosure/listedinfo/announcement/c/2014-12-26/600222_20141227_11.pdf
604,2014-12-27,太龙药业第六届监事会第九次会议决议的公告,/disclosure/listedinfo/announcement/c/2014-12-26/600222_20141227_2.pdf
605,2014-12-27,太龙药业第六届董事会第十四次会议决议的公告,/disclosure/listedinfo/announcement/c/2014-12-26/600222_20141227_1.pdf
606,2014-12-27,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司使用闲置募集资金暂时补充流动资金的核查意见,/disclosure/listedinfo/announcement/c/2014-12-26/600222_20141227_10.pdf
607,2014-12-30,太龙药业关于调整发行股份及支付现金购买资产并募集配套资金暨关联交易方案独立董事事前意见,/disclosure/listedinfo/announcement/c/2014-12-29/600222_20141230_6.pdf
608,2014-12-30,太龙药业关于调整发行股份及支付现金购买资产并募集配套资金暨关联交易方案的审计委员会审核意见,/disclosure/listedinfo/announcement/c/2014-12-29/600222_20141230_7.pdf
609,2014-12-30,太龙药业关于调整发行股份及支付现金购买资产并募集配套资金暨关联交易方案的公告,/disclosure/listedinfo/announcement/c/2014-12-29/600222_20141230_2.pdf
610,2014-12-30,太龙药业关于调整发行股份及支付现金购买资产并募集配套资金暨关联交易方案的独立董事意见,/disclosure/listedinfo/announcement/c/2014-12-29/600222_20141230_5.pdf
611,2014-12-30,太龙药业第六届董事会第一次临时会议决议的公告,/disclosure/listedinfo/announcement/c/2014-12-29/600222_20141230_1.pdf
612,2014-12-30,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易方案调整之独立财务顾问核查意见,/disclosure/listedinfo/announcement/c/2014-12-29/600222_20141230_3.pdf
613,2014-12-30,太龙药业：河南仟问律师事务所关于调整河南太龙药业股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易方案的法律意见书,/disclosure/listedinfo/announcement/c/2014-12-29/600222_20141230_4.pdf
614,2014-12-31,太龙药业关于中国证监会上市公司并购重组审核委员会审核公司发行股份及支付现金购买资产并募集配套资金暨关联交易事项的停牌公告,/disclosure/listedinfo/announcement/c/2014-12-30/600222_20141231_1.pdf
615,2015-01-06,太龙药业关于使用暂时闲置募集资金购买银行理财产品实施情况的公告,/disclosure/listedinfo/announcement/c/2015-01-05/600222_20150106_1.pdf
616,2015-01-10,太龙药业发行股份及支付现金购买资产并募集配套资金暨关联交易事项获得中国证监会并购重组委审核通过暨公司股票复牌的公告,/disclosure/listedinfo/announcement/c/2015-01-09/600222_20150110_1.pdf
617,2015-01-16,太龙药业召开2015年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-01-15/600222_20150116_2.pdf
618,2015-01-16,太龙药业关于与关联方共同对外投资的关联交易的公告,/disclosure/listedinfo/announcement/c/2015-01-15/600222_20150116_1.pdf
619,2015-01-16,太龙药业第六届董事会第十五次会议相关事项审计委员会审核意见,/disclosure/listedinfo/announcement/c/2015-01-15/600222_20150116_6.pdf
620,2015-01-16,太龙药业第六届董事会第十五次会议相关事项独立董事意见,/disclosure/listedinfo/announcement/c/2015-01-15/600222_20150116_4.pdf
621,2015-01-16,太龙药业第六届董事会第十五次会议相关事项独立董事事前意见,/disclosure/listedinfo/announcement/c/2015-01-15/600222_20150116_3.pdf
622,2015-01-16,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司关联交易的核查意见,/disclosure/listedinfo/announcement/c/2015-01-15/600222_20150116_5.pdf
623,2015-01-24,太龙药业2015年第一次临时股东大会会议材料,/disclosure/listedinfo/announcement/c/2015-01-23/600222_20150124_1.pdf
624,2015-01-28,太龙药业关于2015年第一次临时股东大会补充公告,/disclosure/listedinfo/announcement/c/2015-01-27/600222_20150128_1.pdf
625,2015-01-31,太龙药业发行股份及支付现金购买资产并募集配套资金暨关联交易事项获得中国证监会核准的公告,/disclosure/listedinfo/announcement/c/2015-01-30/600222_20150131_1.pdf
626,2015-01-31,太龙药业发行股份及支付现金购买资产并募集配套资金暨关联交易报告书摘要,/disclosure/listedinfo/announcement/c/2015-01-30/600222_20150131_2.pdf
627,2015-01-31,太龙药业发行股份及支付现金购买资产并募集配套资金暨关联交易报告书,/disclosure/listedinfo/announcement/c/2015-01-30/600222_20150131_6.pdf
628,2015-01-31,太龙药业备考财务报表及其审计报告,/disclosure/listedinfo/announcement/c/2015-01-30/600222_20150131_5.pdf
629,2015-01-31,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易报告书之独立财务顾问报告,/disclosure/listedinfo/announcement/c/2015-01-30/600222_20150131_4.pdf
630,2015-01-31,太龙药业：河南仟问律师事务所关于河南太龙药业股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易的补充法律意见书,/disclosure/listedinfo/announcement/c/2015-01-30/600222_20150131_3.pdf
631,2015-02-03,太龙药业2015年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-02-02/600222_20150203_1.pdf
632,2015-02-03,太龙药业2015年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-02-02/600222_20150203_2.pdf
633,2015-02-17,太龙药业关于2014年度第一期短期融资券到期兑付的公告,/disclosure/listedinfo/announcement/c/2015-02-16/600222_20150217_1.pdf
634,2015-03-05,太龙药业关于发行股份及支付现金购买资产并募集配套资金暨关联交易资产过户完成情况的公告,/disclosure/listedinfo/announcement/c/2015-03-04/600222_20150305_1.pdf
635,2015-03-05,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易实施情况之独立财务顾问核查意见,/disclosure/listedinfo/announcement/c/2015-03-04/600222_20150305_2.pdf
636,2015-03-05,太龙药业：河南仟问律师事务所关于河南太龙药业股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易标的资产过户的法律意见书,/disclosure/listedinfo/announcement/c/2015-03-04/600222_20150305_3.pdf
637,2015-03-18,太龙药业关于签订募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2015-03-17/600222_20150318_2.pdf
638,2015-03-18,太龙药业第六届董事会第十六次会议决议的公告,/disclosure/listedinfo/announcement/c/2015-03-17/600222_20150318_1.pdf
639,2015-03-20,太龙药业关于发行股份购买资产并募集配套资金发行结果暨股份变动公告,/disclosure/listedinfo/announcement/c/2015-03-19/600222_20150320_1.pdf
640,2015-03-20,太龙药业发行股份及支付现金购买资产并募集配套资金暨关联交易之募集配套资金非公开发行股票发行情况报告书（摘要）,/disclosure/listedinfo/announcement/c/2015-03-19/600222_20150320_8.pdf
641,2015-03-20,太龙药业发行股份及支付现金购买资产并募集配套资金暨关联交易之募集配套资金非公开发行股票发行情况报告书,/disclosure/listedinfo/announcement/c/2015-03-19/600222_20150320_9.pdf
642,2015-03-20,太龙药业：验资报告（2）,/disclosure/listedinfo/announcement/c/2015-03-19/600222_20150320_4.pdf
643,2015-03-20,太龙药业：验资报告（1）,/disclosure/listedinfo/announcement/c/2015-03-19/600222_20150320_2.pdf
644,2015-03-20,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易之募集配套资金非公开发行股票上市保荐书,/disclosure/listedinfo/announcement/c/2015-03-19/600222_20150320_7.pdf
645,2015-03-20,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易之募集配套资金非公开发行股票发行过程和认购对象合规性的报告,/disclosure/listedinfo/announcement/c/2015-03-19/600222_20150320_6.pdf
646,2015-03-20,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易实施情况之独立财务顾问核查意见,/disclosure/listedinfo/announcement/c/2015-03-19/600222_20150320_5.pdf
647,2015-03-20,太龙药业：河南仟问律师事务所关于河南太龙药业股份有限公司非公开发行股票发行过程和认购对象合规性的法律意见书,/disclosure/listedinfo/announcement/c/2015-03-19/600222_20150320_3.pdf
648,2015-03-28,太龙药业2015年度第一期短期融资券发行情况公告,/disclosure/listedinfo/announcement/c/2015-03-27/600222_20150328_1.pdf
649,2015-04-08,太龙药业与河南中医学院签订中医药战略合作框架协议的公告,/disclosure/listedinfo/announcement/c/2015-04-07/600222_20150408_3.pdf
650,2015-04-08,太龙药业关于子公司河南桦玉实业有限公司完成工商设立登记的公告,/disclosure/listedinfo/announcement/c/2015-04-07/600222_20150408_2.pdf
651,2015-04-08,太龙药业关于全资子公司名称变更的公告,/disclosure/listedinfo/announcement/c/2015-04-07/600222_20150408_1.pdf
652,2015-04-09,太龙药业参股子公司太龙健康产业投资有限公司与江苏金茂创业投资管理有限公司就设立医药产业投资基金签订战略合作框架协议的公告,/disclosure/listedinfo/announcement/c/2015-04-08/600222_20150409_1.pdf
653,2015-04-11,太龙药业审计委员会关于预计2015年度公司及控股子公司与关联方进行日常关联交易的意见,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_27.pdf
654,2015-04-11,太龙药业年报摘要,/disclosure/listedinfo/announcement/c/2015-04-10/600222_2014_nzy.pdf
655,2015-04-11,太龙药业年报,/disclosure/listedinfo/announcement/c/2015-04-10/600222_2014_n.pdf
656,2015-04-11,太龙药业内部控制审计报告,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_21.pdf
657,2015-04-11,太龙药业监事会关于会计政策变更的说明,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_18.pdf
658,2015-04-11,太龙药业关于终止部分募集资金投资项目的公告,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_6.pdf
659,2015-04-11,太龙药业关于召开2014年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_10.pdf
660,2015-04-11,太龙药业关于预计2015年度公司及控股子公司与关联方进行日常关联交易的公告,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_5.pdf
661,2015-04-11,太龙药业关于修订《公司章程》部分条款的公告,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_9.pdf
662,2015-04-11,太龙药业关于会计政策变更的公告,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_8.pdf
663,2015-04-11,太龙药业关于公司董事变动的公告,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_7.pdf
664,2015-04-11,太龙药业股东大会议事规则,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_26.pdf
665,2015-04-11,太龙药业公司章程（2015修订）,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_31.pdf
666,2015-04-11,太龙药业独立董事提名人声明,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_30.pdf
667,2015-04-11,太龙药业独立董事候选人声明（王波）,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_29.pdf
668,2015-04-11,太龙药业独立董事关于公司第六届董事会第十七次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_25.pdf
669,2015-04-11,太龙药业独立董事对公司对外担保情况的专项说明,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_12.pdf
670,2015-04-11,太龙药业独立董事2014年度述职报告,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_15.pdf
671,2015-04-11,太龙药业董事会关于会计政策变更的说明,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_17.pdf
672,2015-04-11,太龙药业第六届监事会第十次会议决议的公告,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_3.pdf
673,2015-04-11,太龙药业第六届董事会第十七次会议决议的公告,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_2.pdf
674,2015-04-11,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司非公开发行股票募集资金投资项目相关事项的核查意见,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_28.pdf
675,2015-04-11,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司2014年度募集资金存放与使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_22.pdf
676,2015-04-11,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司2014年度持续督导报告书,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_24.pdf
677,2015-04-11,太龙药业：关于河南太龙药业股份有限公司控股股东及其他关联方占用资金情况的专项说明,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_14.pdf
678,2015-04-11,太龙药业：关于河南太龙药业股份有限公司会计政策变更的专项说明,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_20.pdf
679,2015-04-11,太龙药业：关于河南太龙药业股份有限公司2014年度募集资金存放与使用情况的鉴证报告,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_19.pdf
680,2015-04-11,太龙药业2014年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_16.pdf
681,2015-04-11,太龙药业2014年度募集资金存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_4.pdf
682,2015-04-11,太龙药业2014年度董事会审计委员会述职报告,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_23.pdf
683,2015-04-11,太龙药业2014年度财务报表审计报告,/disclosure/listedinfo/announcement/c/2015-04-10/600222_20150411_13.pdf
684,2015-04-21,太龙药业2015年第一季度业绩预亏公告,/disclosure/listedinfo/announcement/c/2015-04-20/600222_20150421_1.pdf
685,2015-04-25,太龙药业关于召开2014年度业绩说明会的公告,/disclosure/listedinfo/announcement/c/2015-04-24/600222_20150425_2.pdf
686,2015-04-25,太龙药业第一季度季报,/disclosure/listedinfo/announcement/c/2015-04-24/600222_2015_1.pdf
687,2015-05-01,太龙药业2014年度业绩说明会召开情况公告,/disclosure/listedinfo/announcement/c/2015-04-30/600222_20150501_1.pdf
688,2015-05-01,太龙药业2014年度业绩说明会会议纪要,/disclosure/listedinfo/announcement/c/2015-04-30/600222_20150501_2.pdf
689,2015-05-06,太龙药业参股子公司参股健康产业并购基金的公告,/disclosure/listedinfo/announcement/c/2015-05-05/600222_20150506_1.pdf
690,2015-05-06,太龙药业2014年年度股东大会会议材料,/disclosure/listedinfo/announcement/c/2015-05-05/600222_20150506_2.pdf
691,2015-05-08,太龙药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-05-07/600222_20150508_1.pdf
692,2015-05-08,太龙药业：实际控制人回河南太龙药业股份有限公司复函,/disclosure/listedinfo/announcement/c/2015-05-07/600222_20150508_3.pdf
693,2015-05-08,太龙药业：控股股东回河南太龙药业股份有限公司复函,/disclosure/listedinfo/announcement/c/2015-05-07/600222_20150508_2.pdf
694,2015-05-09,太龙药业关于召开2014年业绩说明会暨投资者网上集体接待日的公告,/disclosure/listedinfo/announcement/c/2015-05-08/600222_20150509_1.pdf
695,2015-05-12,太龙药业股东大会议事规则,/disclosure/listedinfo/announcement/c/2015-05-11/600222_20150512_4.pdf
696,2015-05-12,太龙药业公司章程（2015修订）,/disclosure/listedinfo/announcement/c/2015-05-11/600222_20150512_3.pdf
697,2015-05-12,太龙药业2014年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-05-11/600222_20150512_1.pdf
698,2015-05-12,太龙药业2014年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-05-11/600222_20150512_2.pdf
699,2015-05-13,太龙药业第六届董事会第十九次会议决议的公告,/disclosure/listedinfo/announcement/c/2015-05-12/600222_20150513_1.pdf
700,2015-05-20,太龙药业关于全资子公司桐君堂药业有限公司投资设立子公司的公告,/disclosure/listedinfo/announcement/c/2015-05-19/600222_20150520_1.pdf
701,2015-06-05,太龙药业参股子公司健康产业并购基金对外投资的公告,/disclosure/listedinfo/announcement/c/2015-06-04/600222_20150605_1.pdf
702,2015-06-06,太龙药业关于全资子公司享受税收减免优惠的公告,/disclosure/listedinfo/announcement/c/2015-06-05/600222_20150606_1.pdf
703,2015-06-09,太龙药业参股子公司健康产业并购基金对外投资的补充公告,/disclosure/listedinfo/announcement/c/2015-06-08/600222_20150609_1.pdf
704,2015-07-03,太龙药业2014年度利润分配实施的公告,/disclosure/listedinfo/announcement/c/2015-07-02/600222_20150703_1.pdf
705,2015-07-07,太龙药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-07-06/600222_20150707_1.pdf
706,2015-07-07,太龙药业：太龙药业控股股东有关公司股票异常波动的回函,/disclosure/listedinfo/announcement/c/2015-07-06/600222_20150707_3.pdf
707,2015-07-07,太龙药业：太龙药业股票异常波动实际控制人回函,/disclosure/listedinfo/announcement/c/2015-07-06/600222_20150707_2.pdf
708,2015-07-09,太龙药业关于控股股东拟增持股份的公告,/disclosure/listedinfo/announcement/c/2015-07-08/600222_20150709_1.pdf
709,2015-08-26,太龙药业与吴澜、高世静签订《盈利补偿协议之补充协议书》的公告,/disclosure/listedinfo/announcement/c/2015-08-26/600222_20150826_10.pdf
710,2015-08-26,太龙药业与桐庐县医药药材投资管理有限公司签订《盈利补偿协议之补充协议书》的公告,/disclosure/listedinfo/announcement/c/2015-08-26/600222_20150826_9.pdf
711,2015-08-26,太龙药业关于召开2015年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-08-26/600222_20150826_12.pdf
712,2015-08-26,太龙药业关于闲置募集资金暂时补充流动资金归还的公告,/disclosure/listedinfo/announcement/c/2015-08-26/600222_20150826_13.pdf
713,2015-08-26,太龙药业关于使用暂时闲置的募集资金购买保本型理财产品的公告,/disclosure/listedinfo/announcement/c/2015-08-26/600222_20150826_8.pdf
714,2015-08-26,太龙药业关于使用募集资金对全资子公司增资的公告,/disclosure/listedinfo/announcement/c/2015-08-26/600222_20150826_7.pdf
715,2015-08-26,太龙药业关于全资子公司桐君堂药业有限公司对外投资的公告,/disclosure/listedinfo/announcement/c/2015-08-26/600222_20150826_11.pdf
716,2015-08-26,太龙药业关于部分募集资金投资项目实施地点变更的公告,/disclosure/listedinfo/announcement/c/2015-08-26/600222_20150826_6.pdf
717,2015-08-26,太龙药业关于变更部分募集资金投资项目公告,/disclosure/listedinfo/announcement/c/2015-08-26/600222_20150826_5.pdf
718,2015-08-26,太龙药业第六届监事会第十二次会议决议的公告,/disclosure/listedinfo/announcement/c/2015-08-26/600222_20150826_3.pdf
719,2015-08-26,太龙药业第六届董事会第二十次会议决议的公告,/disclosure/listedinfo/announcement/c/2015-08-26/600222_20150826_2.pdf
720,2015-08-26,太龙药业半年报摘要,/disclosure/listedinfo/announcement/c/2015-08-26/600222_2015_zzy.pdf
721,2015-08-26,太龙药业半年报,/disclosure/listedinfo/announcement/c/2015-08-26/600222_2015_z.pdf
722,2015-08-26,太龙药业：桐庐富昌健身器械厂拟转让持有的桐庐富盛健康产业公司股东全部权益项目评估报告,/disclosure/listedinfo/announcement/c/2015-08-26/600222_20150826_18.pdf
723,2015-08-26,太龙药业：桐君堂扩建营销网络建设项目可行性研究报告,/disclosure/listedinfo/announcement/c/2015-08-26/600222_20150826_16.pdf
724,2015-08-26,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司非公开发行股票募集资金投资项目相关事项的核查意见,/disclosure/listedinfo/announcement/c/2015-08-26/600222_20150826_15.pdf
725,2015-08-26,太龙药业：北京深蓝海医药CRO项目可行性研究报告,/disclosure/listedinfo/announcement/c/2015-08-26/600222_20150826_17.pdf
726,2015-08-26,太龙药业2015年半年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2015-08-26/600222_20150826_4.pdf
727,2015-09-01,太龙药业监事会有关上海证券交易所《关于对河南太龙药业股份有限公司变更募集资金投向有关事项的问询函》相关事项的意见,/disclosure/listedinfo/announcement/c/2015-09-01/600222_20150901_6.pdf
728,2015-09-01,太龙药业关于全资子公司桐君堂药业有限公司对外投资的补充公告,/disclosure/listedinfo/announcement/c/2015-09-01/600222_20150901_2.pdf
729,2015-09-01,太龙药业对上海证券交易所《关于对河南太龙药业股份有限公司变更募集资金投向有关事项的问询函》的回复公告,/disclosure/listedinfo/announcement/c/2015-09-01/600222_20150901_1.pdf
730,2015-09-01,太龙药业独立董事有关上海证券交易所《关于对河南太龙药业股份有限公司变更募集资金投向有关事项的问询函》相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-09-01/600222_20150901_5.pdf
731,2015-09-01,太龙药业：恒泰长财证券有限责任公司关于对河南太龙药业股份有限公司问询函相关事项的核查意见,/disclosure/listedinfo/announcement/c/2015-09-01/600222_20150901_3.pdf
732,2015-09-01,太龙药业：北京兴华会计师事务所（特殊普通合伙）关于对河南太龙药业股份有限公司变更募集资金投向有关事项问询函的回复,/disclosure/listedinfo/announcement/c/2015-09-01/600222_20150901_4.pdf
733,2015-09-01,太龙药业：北京国融兴华资产评估有限责任公司关于对桐庐富盛健康产业有限公司股东全部权益在评估基准日评估增值的说明,/disclosure/listedinfo/announcement/c/2015-09-01/600222_20150901_7.pdf
734,2015-09-11,太龙药业2015年第二次临时股东大会会议材料,/disclosure/listedinfo/announcement/c/2015-09-11/600222_20150911_1.pdf
735,2015-09-19,太龙药业2015年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-09-19/600222_20150919_1.pdf
736,2015-09-19,太龙药业2015年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-09-19/600222_20150919_2.pdf
737,2015-10-13,太龙药业关于子公司河南河洛太龙制药有限公司完成工商设立登记的公告,/disclosure/listedinfo/announcement/c/2015-10-13/600222_20151013_3.pdf
738,2015-10-13,太龙药业关于签订募集资金专户存储监管协议的公告,/disclosure/listedinfo/announcement/c/2015-10-13/600222_20151013_2.pdf
739,2015-10-13,太龙药业第六届董事会第二十一次会议决议的公告,/disclosure/listedinfo/announcement/c/2015-10-13/600222_20151013_1.pdf
740,2015-10-28,太龙药业关于公司2015年1-3季度主要经营数据的公告,/disclosure/listedinfo/announcement/c/2015-10-28/600222_20151028_2.pdf
741,2015-10-28,太龙药业第三季度季报,/disclosure/listedinfo/announcement/c/2015-10-28/600222_2015_3.pdf
742,2015-11-11,太龙药业关于使用暂时闲置募集资金购买银行理财产品实施情况的公告,/disclosure/listedinfo/announcement/c/2015-11-11/600222_20151111_1.pdf
743,2015-11-13,太龙药业关于使用暂时闲置募集资金购买银行理财产品实施情况的公告,/disclosure/listedinfo/announcement/c/2015-11-13/600222_20151113_1.pdf
744,2015-12-31,太龙药业关于控股子公司完成工商变更的公告,/disclosure/listedinfo/announcement/c/2015-12-31/600222_20151231_1.pdf
745,2015-12-31,太龙药业关于参股投资的郑州银行股份有限公司在香港联合交易所有限公司挂牌上市的提示性公告,/disclosure/listedinfo/announcement/c/2015-12-31/600222_20151231_2.pdf
746,2016-01-19,太龙药业关于控股子公司完成工商变更的公告,/disclosure/listedinfo/announcement/c/2016-01-19/600222_20160119_1.pdf
747,2016-01-20,太龙药业关于公司药品注册申请的提示性公告,/disclosure/listedinfo/announcement/c/2016-01-20/600222_20160120_1.pdf
748,2016-01-30,太龙药业2015年年度业绩预减公告,/disclosure/listedinfo/announcement/c/2016-01-30/600222_20160130_1.pdf
749,2016-02-19,太龙药业关于小儿复方鸡内金咀嚼片获得药品补充申请批件的公告,/disclosure/listedinfo/announcement/c/2016-02-19/600222_20160219_1.pdf
750,2016-03-12,太龙药业关于控股股东增持股份进展的公告,/disclosure/listedinfo/announcement/c/2016-03-12/600222_20160312_1.pdf
751,2016-03-18,太龙药业关于终止部分募集资金投资项目并将剩余募集资金永久补充流动资金的公告,/disclosure/listedinfo/announcement/c/2016-03-18/600222_20160318_2.pdf
752,2016-03-18,太龙药业关于召开2016年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-03-18/600222_20160318_3.pdf
753,2016-03-18,太龙药业第六届监事会第十四次会议决议的公告,/disclosure/listedinfo/announcement/c/2016-03-18/600222_20160318_4.pdf
754,2016-03-18,太龙药业第六届董事会第二十三次会议决议的公告,/disclosure/listedinfo/announcement/c/2016-03-18/600222_20160318_1.pdf
755,2016-03-18,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司终止部分募集资金投资项目并将剩余募集资金永久补充流动资金的核查意见,/disclosure/listedinfo/announcement/c/2016-03-18/600222_20160318_5.pdf
756,2016-03-29,太龙药业关于2015年度第一期短期融资券到期兑付的公告,/disclosure/listedinfo/announcement/c/2016-03-29/600222_20160329_1.pdf
757,2016-03-29,太龙药业2016年第一次临时股东大会会议材料,/disclosure/listedinfo/announcement/c/2016-03-29/600222_20160329_2.pdf
758,2016-04-07,太龙药业2016年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-04-07/600222_20160407_1.pdf
759,2016-04-07,太龙药业2016年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-04-07/600222_20160407_2.pdf
760,2016-04-09,太龙药业关于控股股东增持股份进展的公告,/disclosure/listedinfo/announcement/c/2016-04-09/600222_20160409_1.pdf
761,2016-04-16,太龙药业总经理工作细则,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_24.pdf
762,2016-04-16,太龙药业审计委员会关于2015年度日常关联交易情况及预计2016年度公司及控股子公司与关联方进行日常关联交易的意见,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_27.pdf
763,2016-04-16,太龙药业年报摘要,/disclosure/listedinfo/announcement/c/2016-04-16/600222_2015_nzy.pdf
764,2016-04-16,太龙药业年报,/disclosure/listedinfo/announcement/c/2016-04-16/600222_2015_n.pdf
765,2016-04-16,太龙药业关于召开2015年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_9.pdf
766,2016-04-16,太龙药业关于修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_7.pdf
767,2016-04-16,太龙药业关于公司董事变动的公告,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_6.pdf
768,2016-04-16,太龙药业关于2016年度公司在金融机构进行间接融资额度的公告,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_8.pdf
769,2016-04-16,太龙药业关于2015年度未实现盈利预测的说明及致歉,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_19.pdf
770,2016-04-16,太龙药业关于2015年度日常关联交易情况及预计2016年度公司及控股子公司与关联方进行日常关联交易的公告,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_4.pdf
771,2016-04-16,太龙药业股东大会议事规则,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_23.pdf
772,2016-04-16,太龙药业公司章程（2016修订）,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_30.pdf
773,2016-04-16,太龙药业独立董事关于公司第六届董事会第二十四次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_26.pdf
774,2016-04-16,太龙药业独立董事关于2015年度日常关联交易情况及预计2016年度公司及控股子公司与关联方进行日常关联交易事前认可的意见,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_25.pdf
775,2016-04-16,太龙药业独立董事对公司对外担保情况的专项说明,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_11.pdf
776,2016-04-16,太龙药业独立董事2015年度述职报告,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_14.pdf
777,2016-04-16,太龙药业董事会审计委员会2015年度述职报告,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_18.pdf
778,2016-04-16,太龙药业董事长、总经理关于公司2015年度未实现盈利预测的说明及致歉公告,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_31.pdf
779,2016-04-16,太龙药业第六届监事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_3.pdf
780,2016-04-16,太龙药业第六届董事会第二十四次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_2.pdf
781,2016-04-16,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司未实现2015年度盈利预测的说明及致歉,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_20.pdf
782,2016-04-16,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易2015年度持续督导意见,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_21.pdf
783,2016-04-16,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司2015年度募集资金存放与使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_28.pdf
784,2016-04-16,太龙药业：关于盈利预测实现情况及业绩承诺实现情况的专项审核报告,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_16.pdf
785,2016-04-16,太龙药业：关于河南太龙药业股份有限公司控股股东及其他关联方占用资金情况的专项说明,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_13.pdf
786,2016-04-16,太龙药业：关于河南太龙药业股份有限公司2015年度募集资金存放与使用情况的鉴证报告,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_29.pdf
787,2016-04-16,太龙药业：北京兴华会计师事务所（特殊普通合伙）关于河南太龙药业股份有限公司未实现2015年度盈利预测的说明及致歉,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_22.pdf
788,2016-04-16,太龙药业2015年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_17.pdf
789,2016-04-16,太龙药业2015年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_15.pdf
790,2016-04-16,太龙药业2015年度募集资金存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_5.pdf
791,2016-04-16,太龙药业2015年度财务报表审计报告,/disclosure/listedinfo/announcement/c/2016-04-16/600222_20160416_12.pdf
792,2016-04-19,太龙药业关于续聘北京兴华会计师事务所（特殊普通合伙）为公司2016年度财务及内部控制审计机构的公告,/disclosure/listedinfo/announcement/c/2016-04-19/600222_20160419_1.pdf
793,2016-04-30,太龙药业关于召开2015年度业绩说明会的公告,/disclosure/listedinfo/announcement/c/2016-04-30/600222_20160430_3.pdf
794,2016-04-30,太龙药业关于公司2016年一季度主要经营数据的公告,/disclosure/listedinfo/announcement/c/2016-04-30/600222_20160430_1.pdf
795,2016-04-30,太龙药业2016年第一季度报告,/disclosure/listedinfo/announcement/c/2016-04-30/600222_2016_1.pdf
796,2016-05-04,太龙药业2015年年度股东大会会议材料,/disclosure/listedinfo/announcement/c/2016-05-04/600222_20160504_1.pdf
797,2016-05-05,太龙药业2015年度业绩说明会召开情况公告,/disclosure/listedinfo/announcement/c/2016-05-05/600222_20160505_1.pdf
798,2016-05-10,太龙药业关于收到上海证券交易所对公司2015年年度报告的事后审核问询函的公告,/disclosure/listedinfo/announcement/c/2016-05-10/600222_20160510_1.pdf
799,2016-05-10,太龙药业关于控股股东增持股份进展的公告,/disclosure/listedinfo/announcement/c/2016-05-10/600222_20160510_2.pdf
800,2016-05-12,太龙药业股东大会议事规则,/disclosure/listedinfo/announcement/c/2016-05-12/600222_20160512_2.pdf
801,2016-05-12,太龙药业公司章程（2016修订）,/disclosure/listedinfo/announcement/c/2016-05-12/600222_20160512_1.pdf
802,2016-05-12,太龙药业第六届董事会第二十六次会议决议的公告,/disclosure/listedinfo/announcement/c/2016-05-12/600222_20160512_4.pdf
803,2016-05-12,太龙药业2015年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-05-12/600222_20160512_3.pdf
804,2016-05-12,太龙药业2015年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-05-12/600222_20160512_5.pdf
805,2016-05-26,太龙药业关于2015年年度报告的事后审核问询函回复的公告,/disclosure/listedinfo/announcement/c/2016-05-26/600222_20160526_1.pdf
806,2016-05-26,太龙药业独立董事关于上海证券交易所《关于河南太龙药业股份有限公司2015年年度报告的事后审核问询函》相关问题之回复意见,/disclosure/listedinfo/announcement/c/2016-05-26/600222_20160526_2.pdf
807,2016-05-26,太龙药业：桐君堂药业有限公司2015年度募集资金增资项目的独立核算报告,/disclosure/listedinfo/announcement/c/2016-05-26/600222_20160526_5.pdf
808,2016-05-26,太龙药业：恒泰长财证券有限责任公司关于对河南太龙药业股份有限公司问询函相关事项的核查意见,/disclosure/listedinfo/announcement/c/2016-05-26/600222_20160526_3.pdf
809,2016-05-26,太龙药业：关于桐君堂药业有限公司业绩承诺剔除项目业绩情况的专项审核报告,/disclosure/listedinfo/announcement/c/2016-05-26/600222_20160526_8.pdf
810,2016-05-26,太龙药业：关于河南太龙药业股份有限公司2015年年度报告的事后审核问询函的说明,/disclosure/listedinfo/announcement/c/2016-05-26/600222_20160526_6.pdf
811,2016-05-26,太龙药业：关于北京新领先医药科技发展有限公司业绩承诺剔除项目业绩情况的专项审核报告,/disclosure/listedinfo/announcement/c/2016-05-26/600222_20160526_7.pdf
812,2016-05-26,太龙药业：北京新领先医药科技发展有限公司2015年度募集资金增资项目的独立核算报告,/disclosure/listedinfo/announcement/c/2016-05-26/600222_20160526_4.pdf
813,2016-05-31,太龙药业非公开发行限售股上市流通公告,/disclosure/listedinfo/announcement/c/2016-05-31/600222_20160531_1.pdf
814,2016-05-31,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司发行股份及支付现金购买资产并募集配套资金限售股上市流通的核查意见,/disclosure/listedinfo/announcement/c/2016-05-31/600222_20160531_2.pdf
815,2016-05-31,太龙药业：关于桐君堂药业有限公司业绩承诺实现情况的专项审核报告,/disclosure/listedinfo/announcement/c/2016-05-31/600222_20160531_4.pdf
816,2016-05-31,太龙药业：关于北京新领先医药科技发展有限公司业绩承诺实现情况的专项审核报告,/disclosure/listedinfo/announcement/c/2016-05-31/600222_20160531_3.pdf
817,2016-06-03,太龙药业关于完成工商变更登记及营业执照、组织机构代码证、税务登记证“三证合一”的公告,/disclosure/listedinfo/announcement/c/2016-06-03/600222_20160603_1.pdf
818,2016-06-09,太龙药业关于控股股东增持股份进展的公告,/disclosure/listedinfo/announcement/c/2016-06-09/600222_20160609_1.pdf
819,2016-06-28,太龙药业关于收到控股股东《关于巩义市竹林镇人民政府拟处置巩义市竹林金竹商贸有限公司及巩义市竹林力天科技开发有限公司部分股权的通知》的公告,/disclosure/listedinfo/announcement/c/2016-06-28/600222_20160628_1.pdf
820,2016-06-29,太龙药业关于收到控股股东《关于巩义市竹林镇人民政府拟处置巩义市竹林金竹商贸有限公司及巩义市竹林力天科技开发有限公司部分股权的通知》的补充公告,/disclosure/listedinfo/announcement/c/2016-06-29/600222_20160629_1.pdf
821,2016-07-02,太龙药业关于控股股东增持股份计划实施完成的公告,/disclosure/listedinfo/announcement/c/2016-07-02/600222_20160702_1.pdf
822,2016-07-23,太龙药业关于股东减持股份计划的公告,/disclosure/listedinfo/announcement/c/2016-07-23/600222_20160723_1.pdf
823,2016-07-30,太龙药业拟转让其持有的河南桦玉实业有限公司股权项目资产评估报告,/disclosure/listedinfo/announcement/c/2016-07-30/600222_20160730_5.pdf
824,2016-07-30,太龙药业关于召开2016年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-07-30/600222_20160730_3.pdf
825,2016-07-30,太龙药业独立董事关于转让桦玉股权的独立意见,/disclosure/listedinfo/announcement/c/2016-07-30/600222_20160730_4.pdf
826,2016-07-30,太龙药业第六届董事会第二十七次会议决议的公告,/disclosure/listedinfo/announcement/c/2016-07-30/600222_20160730_1.pdf
827,2016-07-30,太龙药业出售资产暨关联交易的公告,/disclosure/listedinfo/announcement/c/2016-07-30/600222_20160730_2.pdf
828,2016-08-06,太龙药业出售资产暨关联交易的更正公告,/disclosure/listedinfo/announcement/c/2016-08-06/600222_20160806_2.pdf
829,2016-08-06,太龙药业：河南桦玉实业有限公司2016年1-3月财务报表审计报告,/disclosure/listedinfo/announcement/c/2016-08-06/600222_20160806_3.pdf
830,2016-08-06,太龙药业：河南桦玉实业有限公司2015年度财务报表审计报告,/disclosure/listedinfo/announcement/c/2016-08-06/600222_20160806_4.pdf
831,2016-08-06,太龙药业2016年第二次临时股东大会会议材料,/disclosure/listedinfo/announcement/c/2016-08-06/600222_20160806_1.pdf
832,2016-08-16,太龙药业2016年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-08-16/600222_20160816_1.pdf
833,2016-08-16,太龙药业2016年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-08-16/600222_20160816_2.pdf
834,2016-08-20,太龙药业信息披露暂缓与豁免业务管理制度,/disclosure/listedinfo/announcement/c/2016-08-20/600222_20160820_14.pdf
835,2016-08-20,太龙药业投资者关系管理制度,/disclosure/listedinfo/announcement/c/2016-08-20/600222_20160820_13.pdf
836,2016-08-20,太龙药业关于召开2016年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-08-20/600222_20160820_6.pdf
837,2016-08-20,太龙药业关于选举第七届监事会职工监事的公告,/disclosure/listedinfo/announcement/c/2016-08-20/600222_20160820_5.pdf
838,2016-08-20,太龙药业独立董事提名人声明,/disclosure/listedinfo/announcement/c/2016-08-20/600222_20160820_12.pdf
839,2016-08-20,太龙药业独立董事候选人声明（周正国）,/disclosure/listedinfo/announcement/c/2016-08-20/600222_20160820_11.pdf
840,2016-08-20,太龙药业独立董事候选人声明（张复生）,/disclosure/listedinfo/announcement/c/2016-08-20/600222_20160820_10.pdf
841,2016-08-20,太龙药业独立董事候选人声明（王波）,/disclosure/listedinfo/announcement/c/2016-08-20/600222_20160820_9.pdf
842,2016-08-20,太龙药业独立董事关于公司第六届董事会第二十八次会议相关议案的独立意见,/disclosure/listedinfo/announcement/c/2016-08-20/600222_20160820_8.pdf
843,2016-08-20,太龙药业第六届监事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-20/600222_20160820_3.pdf
844,2016-08-20,太龙药业第六届董事会第二十八次会议决议的公告,/disclosure/listedinfo/announcement/c/2016-08-20/600222_20160820_2.pdf
845,2016-08-20,太龙药业2016年半年度募集资金存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2016-08-20/600222_20160820_4.pdf
846,2016-08-20,太龙药业2016年半年度报告摘要,/disclosure/listedinfo/announcement/c/2016-08-20/600222_2016_zzy.pdf
847,2016-08-20,太龙药业2016年半年度报告,/disclosure/listedinfo/announcement/c/2016-08-20/600222_2016_z.pdf
848,2016-08-31,太龙药业2016年第三次临时股东大会会议材料,/disclosure/listedinfo/announcement/c/2016-08-31/600222_20160831_1.pdf
849,2016-09-08,太龙药业独立董事关于公司第七届董事会第一次会议相关议案独立意见,/disclosure/listedinfo/announcement/c/2016-09-08/600222_20160908_5.pdf
850,2016-09-08,太龙药业第七届监事会第一次会议决议的公告,/disclosure/listedinfo/announcement/c/2016-09-08/600222_20160908_3.pdf
851,2016-09-08,太龙药业第七届董事会第一次会议决议的公告,/disclosure/listedinfo/announcement/c/2016-09-08/600222_20160908_2.pdf
852,2016-09-08,太龙药业2016年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-09-08/600222_20160908_1.pdf
853,2016-09-08,太龙药业2016年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-09-08/600222_20160908_4.pdf
854,2016-10-18,太龙药业关于控股子公司股东及法定代表人等变更的公告,/disclosure/listedinfo/announcement/c/2016-10-18/600222_20161018_1.pdf
855,2016-10-27,太龙药业关于公司2016年1-3季度主要经营数据的公告,/disclosure/listedinfo/announcement/c/2016-10-27/600222_20161027_2.pdf
856,2016-10-27,太龙药业2016年第三季度报告,/disclosure/listedinfo/announcement/c/2016-10-27/600222_2016_3.pdf
857,2016-11-11,太龙药业关于变更持续督导独立财务顾问主办人的公告,/disclosure/listedinfo/announcement/c/2016-11-11/600222_20161111_1.pdf
858,2016-12-01,太龙药业关于控股股东部分股权质押的公告,/disclosure/listedinfo/announcement/c/2016-12-01/600222_20161201_1.pdf
859,2016-12-03,太龙药业拟转让所持焦作怀牌饮料有限公司股权项目评估报告,/disclosure/listedinfo/announcement/c/2016-12-03/600222_20161203_3.pdf
860,2016-12-03,太龙药业关于出售控股子公司部分股权的公告,/disclosure/listedinfo/announcement/c/2016-12-03/600222_20161203_2.pdf
861,2016-12-03,太龙药业第七届董事会第三次会议决议的公告,/disclosure/listedinfo/announcement/c/2016-12-03/600222_20161203_1.pdf
862,2016-12-03,太龙药业：北京兴华会计师事务所（特殊普通合伙）关于焦作太龙大健康食品有限公司2015年度财务报表审计报告,/disclosure/listedinfo/announcement/c/2016-12-03/600222_20161203_4.pdf
863,2016-12-07,太龙药业关于出售控股子公司部分股权的补充披露公告,/disclosure/listedinfo/announcement/c/2016-12-07/600222_20161207_1.pdf
864,2017-02-07,太龙药业关于股东减持计划实施情况的公告,/disclosure/listedinfo/announcement/c/2017-02-07/600222_20170207_1.pdf
865,2017-02-25,太龙药业关于控股股东股权解除质押的公告,/disclosure/listedinfo/announcement/c/2017-02-25/600222_20170225_1.pdf
866,2017-02-25,太龙药业关于公司产品新纳入国家医保目录的公告,/disclosure/listedinfo/announcement/c/2017-02-25/600222_20170225_2.pdf
867,2017-03-18,太龙药业关于实际控制人部分股权变更过户完成的公告,/disclosure/listedinfo/announcement/c/2017-03-18/600222_20170318_1.pdf
868,2017-03-21,太龙药业关于停牌的提示性公告,/disclosure/listedinfo/announcement/c/2017-03-21/600222_20170321_2.pdf
869,2017-03-21,太龙药业关于收到上海证券交易所问询函的公告,/disclosure/listedinfo/announcement/c/2017-03-21/600222_20170321_1.pdf
870,2017-03-23,太龙药业关于回复上海证券交易所问询函的公告,/disclosure/listedinfo/announcement/c/2017-03-23/600222_20170323_1.pdf
871,2017-03-23,太龙药业关于复牌的提示性公告,/disclosure/listedinfo/announcement/c/2017-03-23/600222_20170323_2.pdf
872,2017-03-23,太龙药业：中联资产评估集团有限公司对《关于对河南太龙药业股份有限公司实际控制人股权变更事项的问询函》（上证公函[2017]0293号）资产评估相关问题的核查意见,/disclosure/listedinfo/announcement/c/2017-03-23/600222_20170323_5.pdf
873,2017-03-23,太龙药业：巩义市竹林镇人民政府拟转让其持有的巩义市竹林力天科技开发有限公司部分股权项目资产评估报告,/disclosure/listedinfo/announcement/c/2017-03-23/600222_20170323_4.pdf
874,2017-03-23,太龙药业：巩义市竹林镇人民政府拟转让其持有的巩义市竹林金竹商贸有限公司部分股权项目资产评估报告,/disclosure/listedinfo/announcement/c/2017-03-23/600222_20170323_3.pdf
875,2017-03-29,太龙药业关于相关内幕信息知情人交易公司股票情况查询结果的公告,/disclosure/listedinfo/announcement/c/2017-03-29/600222_20170329_1.pdf
876,2017-04-01,太龙药业关于召开2016年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_10.pdf
877,2017-04-01,太龙药业关于预计2017年度公司及控股子公司与关联方进行日常关联交易的公告,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_5.pdf
878,2017-04-01,太龙药业关于续聘北京兴华会计师事务所（特殊普通合伙）为公司2017年度财务及内部控制审计机构的公告,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_4.pdf
879,2017-04-01,太龙药业关于将丹参酮ⅡA磺酸钠原料及冻干粉针产品研发投入费用化的公告,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_7.pdf
880,2017-04-01,太龙药业关于计提公司全资子公司河南河洛太龙制药有限公司生产性机器设备减值准备的公告,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_8.pdf
881,2017-04-01,太龙药业关于2017年度公司及所属子公司向银行申请综合授信额度的公告,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_9.pdf
882,2017-04-01,太龙药业独立董事关于预计2017年度公司及控股子公司与关联方进行日常关联交易事前认可的意见,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_22.pdf
883,2017-04-01,太龙药业独立董事关于公司第七届董事会第四次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_23.pdf
884,2017-04-01,太龙药业独立董事对公司对外担保情况的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_12.pdf
885,2017-04-01,太龙药业独立董事2016年度述职报告,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_15.pdf
886,2017-04-01,太龙药业董事会审计委员会2016年度述职报告,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_20.pdf
887,2017-04-01,太龙药业第七届监事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_3.pdf
888,2017-04-01,太龙药业第七届董事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_2.pdf
889,2017-04-01,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司2016年度募集资金存放与使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_24.pdf
890,2017-04-01,太龙药业：关于桐君堂药业有限公司业绩承诺实现情况的专项审核报告,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_21.pdf
891,2017-04-01,太龙药业：关于河南太龙药业股份有限公司控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_14.pdf
892,2017-04-01,太龙药业：关于河南太龙药业股份有限公司2016年度募集资金存放与使用情况的鉴证报告,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_17.pdf
893,2017-04-01,太龙药业：关于河南太龙药业股份有限公司2016年度募集资金存放与使用情况的鉴证报告,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_25.pdf
894,2017-04-01,太龙药业：关于北京新领先医药科技发展有限公司业绩承诺实现情况的专项审核报告,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_18.pdf
895,2017-04-01,太龙药业：2016年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_19.pdf
896,2017-04-01,太龙药业：2016年度财务报表审计报告,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_13.pdf
897,2017-04-01,太龙药业2016年年度报告摘要,/disclosure/listedinfo/announcement/c/2017-04-01/600222_2016_nzy.pdf
898,2017-04-01,太龙药业2016年年度报告,/disclosure/listedinfo/announcement/c/2017-04-01/600222_2016_n.pdf
899,2017-04-01,太龙药业2016年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_16.pdf
900,2017-04-01,太龙药业2016年度募集资金存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-04-01/600222_20170401_6.pdf
901,2017-04-08,太龙药业关于召开2016年度业绩说明会的公告,/disclosure/listedinfo/announcement/c/2017-04-08/600222_20170408_1.pdf
902,2017-04-12,太龙药业关于收到2016年度持续督导意见暨持续督导总结报告的提示性公告,/disclosure/listedinfo/announcement/c/2017-04-12/600222_20170412_1.pdf
903,2017-04-12,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易2016年度持续督导意见暨持续督导总结报告,/disclosure/listedinfo/announcement/c/2017-04-12/600222_20170412_3.pdf
904,2017-04-13,太龙药业2016年度业绩说明会召开情况的公告,/disclosure/listedinfo/announcement/c/2017-04-13/600222_20170413_1.pdf
905,2017-04-14,太龙药业2016年年度股东大会会议材料,/disclosure/listedinfo/announcement/c/2017-04-14/600222_20170414_1.pdf
906,2017-04-22,太龙药业2016年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-04-22/600222_20170422_1.pdf
907,2017-04-22,太龙药业2016年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-04-22/600222_20170422_2.pdf
908,2017-04-26,太龙药业关于部分固定资产报废处理的公告,/disclosure/listedinfo/announcement/c/2017-04-26/600222_20170426_4.pdf
909,2017-04-26,太龙药业关于2017年第一季度主要经营数据的公告,/disclosure/listedinfo/announcement/c/2017-04-26/600222_20170426_5.pdf
910,2017-04-26,太龙药业独立董事关于部分固定资产报废处理的独立意见,/disclosure/listedinfo/announcement/c/2017-04-26/600222_20170426_7.pdf
911,2017-04-26,太龙药业第七届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-26/600222_20170426_3.pdf
912,2017-04-26,太龙药业第七届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-26/600222_20170426_2.pdf
913,2017-04-26,太龙药业2017年第一季度报告,/disclosure/listedinfo/announcement/c/2017-04-26/600222_2017_1.pdf
914,2017-04-29,太龙药业关于收到上海证券交易所对公司2016年年度报告的事后审核问询函的公告,/disclosure/listedinfo/announcement/c/2017-04-29/600222_20170429_1.pdf
915,2017-05-09,太龙药业关于2016年年度报告及摘要修订说明的公告,/disclosure/listedinfo/announcement/c/2017-05-09/600222_20170509_5.pdf
916,2017-05-09,太龙药业关于2016年年度报告的事后审核问询函的回复公告,/disclosure/listedinfo/announcement/c/2017-05-09/600222_20170509_1.pdf
917,2017-05-09,太龙药业独立董事关于上海证券交易所《关于河南太龙药业股份有限公司2016年年度报告的事后审核问询函》相关问题之回复意见,/disclosure/listedinfo/announcement/c/2017-05-09/600222_20170509_3.pdf
918,2017-05-09,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司2016年年度报告问询函相关事项的核查意见,/disclosure/listedinfo/announcement/c/2017-05-09/600222_20170509_4.pdf
919,2017-05-09,太龙药业：北京兴华会计师事务所关于河南太龙药业股份有限公司2016年年度报告的事后审核问询函说明,/disclosure/listedinfo/announcement/c/2017-05-09/600222_20170509_2.pdf
920,2017-05-09,太龙药业2016年年度报告摘要（修订版）,/disclosure/listedinfo/announcement/c/2017-05-09/600222_2016_nzy.pdf
921,2017-05-09,太龙药业2016年年度报告（修订版）,/disclosure/listedinfo/announcement/c/2017-05-09/600222_2016_n.pdf
922,2017-05-16,太龙药业非公开发行限售股上市流通公告,/disclosure/listedinfo/announcement/c/2017-05-16/600222_20170516_1.pdf
923,2017-05-16,太龙药业：恒泰长财证券有限责任公司关于河南太龙药业股份有限公司发行股份及支付现金购买资产并募集配套资金限售股上市流通的核查意见,/disclosure/listedinfo/announcement/c/2017-05-16/600222_20170516_2.pdf
924,2017-05-26,太龙药业关于举行投资者网上集体接待日活动的公告,/disclosure/listedinfo/announcement/c/2017-05-26/600222_20170526_1.pdf
925,2017-06-13,太龙药业关于公司收到政府补贴的公告,/disclosure/listedinfo/announcement/c/2017-06-13/600222_20170613_1.pdf
926,2017-08-19,太龙药业关于执行新会计准则的公告,/disclosure/listedinfo/announcement/c/2017-08-19/600222_20170819_6.pdf
927,2017-08-19,太龙药业关于对外捐赠的公告,/disclosure/listedinfo/announcement/c/2017-08-19/600222_20170819_8.pdf
928,2017-08-19,太龙药业独立董事关于第七届董事会第六次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-08-19/600222_20170819_7.pdf
929,2017-08-19,太龙药业第七届监事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-19/600222_20170819_4.pdf
930,2017-08-19,太龙药业第七届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-19/600222_20170819_3.pdf
931,2017-08-19,太龙药业2017年半年度主要经营数据的公告,/disclosure/listedinfo/announcement/c/2017-08-19/600222_20170819_9.pdf
932,2017-08-19,太龙药业2017年半年度募集资金存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-08-19/600222_20170819_5.pdf
933,2017-08-19,太龙药业2017年半年度报告摘要,/disclosure/listedinfo/announcement/c/2017-08-19/600222_2017_zzy.pdf
934,2017-08-19,太龙药业2017年半年度报告,/disclosure/listedinfo/announcement/c/2017-08-19/600222_2017_z.pdf
935,2017-10-28,太龙药业关于2017年三季度主要经营数据的公告,/disclosure/listedinfo/announcement/c/2017-10-28/600222_20171028_1.pdf
936,2017-10-28,太龙药业2017年第三季度报告,/disclosure/listedinfo/announcement/c/2017-10-28/600222_2017_3.pdf
937,2017-12-07,太龙药业关于收到政府补贴的公告,/disclosure/listedinfo/announcement/c/2017-12-07/600222_20171207_1.pdf
938,2017-12-16,太龙药业关于使用闲置自有资金购买保本型银行理财产品的公告,/disclosure/listedinfo/announcement/c/2017-12-16/600222_20171216_2.pdf
939,2017-12-16,太龙药业独立董事关于公司使用闲置自有资金购买保本型银行理财产品的独立意见,/disclosure/listedinfo/announcement/c/2017-12-16/600222_20171216_3.pdf
940,2017-12-16,太龙药业第七届董事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-16/600222_20171216_1.pdf
941,2017-12-29,太龙药业关于收到政府补助的公告,/disclosure/listedinfo/announcement/c/2017-12-29/600222_20171229_1.pdf
942,2017-12-30,太龙药业关于使用闲置自有资金购买保本型银行理财产品的进展公告,/disclosure/listedinfo/announcement/c/2017-12-30/600222_20171230_1.pdf
943,2018-01-30,太龙药业关于下属子公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2018-01-30/600222_20180130_1.pdf
944,2018-02-10,太龙药业关于获得高新技术企业证书的公告,/disclosure/listedinfo/announcement/c/2018-02-10/600222_20180210_1.pdf
